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There is an increasing demand for total knee arthroplasty (TKA) and 
unicompartmental knee arthroplasty (UKA), and there is also an increasing number of 
revisions. To increase quality and patient satisfaction, new implants and techniques 
are developed. Computer assisted surgery (CAS) was introduced to TKA to improve 
implant position and alignment of the leg, which theoretically improves knee function 
and implant survival. The objective of this thesis was to compare CAS to 
conventional knee arthroplasty (CON) in implant survival, radiological and patient-
reported outcomes (PROs). It also analyzes time trends in implant survival and 
revision causes for TKA and UKA, to evaluate the success of previous developments 
and to assess the need for further improvement. 
Methods 
The thesis is based on two registry studies and one follow-up study from a 
randomized controlled trial (RCT). 
Paper I used the Norwegian Arthroplasty Register (NAR) to compare CAS and CON 
in TKA with respect to implant survival, relative risk of revision and revision causes 
at up to 8 years of follow-up. In paper II, two 11-year periods of TKAs and UKAs 
(period 1: 1994-2004; period 2: 2005-2015) from the NAR were compared regarding 
survivorship and risk of revision due to different revision causes in the latest time 
period relative to the first. Paper III is a 5-year follow-up from an RCT with 192 
patients undergoing TKA with either CAS or CON. The outcomes were migration of 
the tibial component measured by radiostereometric analysis (RSA) in addition to 
radiolucent lines, PROs and the proportion of responders. 
Results 
Paper I showed no significant difference in survival or Cox relative risk of revision 
(RR) for CAS relative to CON (RR=0.8, CI: 0.7-1.0), but CAS had significantly 
fewer revisions due to malalignment (RR=0.5, CI: 0.3-0.9). Paper II showed that 10 
years implant survival was improved for TKA from 91% in period 1 to 94% in period 
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2 (p<0.001), and there was an increasing risk of early revisions for infection. For 
UKA, 10 years survival was 80% in period 1 and 81% in period 2 (p=0.3), and the 
risk of revision caused by progression of osteoarthritis was increased. In paper III, 
CAS and CON did not differ in implant migration or the occurrence of radiolucent 
lines. Patients operated with CAS and CON had similar improvement in PROs from 
preoperative to 5 years. The CAS group had significantly more patients with a high 
improvement in pain scores (p=0.04). 
Conclusions 
The last two decades, implant survival has improved for TKA, but not for UKA. 
Patients operated with CAS and CON had similar migration of the tibial component, 
but CAS had better pain relief 5 years postoperatively. There was no statistically 
significant difference in survival for CAS compared to CON at 8 years. 
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Knee osteoarthritis is a common disease in Norway and worldwide [1-4]. 
Osteoarthritis is a degenerative disease of the knee joint in which the cartilage of the 
knee is damaged. This leads to loss of cartilage, a narrow joint space and bone spurs. 
In end-stage osteoarthritis, there is a complete loss of cartilage in one or more 
compartments of the knee joint. In these cases, the patient often experiences severe 
knee pain, stiffness and reduced knee function. The treatment of osteoarthritis 
depends on patient age and the severity of the osteoarthritis. At an early stage, 
osteoarthritis is treated by non-surgical treatment, such as education, exercise, weight 
reduction, physiotherapy, and analgesic drugs. Patients with severe knee osteoarthritis 
can be assessed for surgical treatment with osteotomy or knee arthroplasty, which is a 
common and effective treatment against end-stage osteoarthritis [4, 5].  
In 2018, 6905 primary knee arthroplasties were performed in Norway, which has 
increased from around 1000 annual procedures in 1994. The proportion of 
unicompartmental knee arthroplasty (UKA) has increased to 14.5% in 2018, from 
9.4% in 2010 [3]. The lifetime risk of having a total knee arthroplasty in Norway in 
2013 was 9.7% for females and 5.8% for males, and this risk has increased from 
6.6% and 2.8% respectively in 2003 [6]. In some other developed countries (i.e. 
Finland and Australia) the lifetime risk for receiving a total knee arthroplasty (TKA) 
is twice as high as in Norway [6]. The rate of UKAs in the United States increased 
during 2002 to 2011, and a high proportion of the operations were performed in 
patients <65 years [7]. 
Using implant revision as the end point, TKA is a successful treatment against end 
stage knee osteoarthritis. The NAR reports in 2019 that 10 years survival is 94.6% for 
TKA. The most common unicompartmental implant in 1994-2013, the Oxford Uni 
(III), had a 10 years survival of 84.2% [3]. A Norwegian study found 95.5% 10 years 
survival for fixed bearing TKAs operated in Norway in 2003-2014 [8]. In Australia, 
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the cumulative revision rate is 5.3% at 10 years for patients with osteoarthritis [9], 
whereas the rate is around 4% in the UK and Sweden [10, 11]. For UKAs, 10 years 
cumulative revision rate is 15% in Australia [9], 11% in England and Wales [10]. 
In the United States and in England and Wales, the need for knee arthroplasties and 
revision knee arthroplasties is expected to increase further in the future [12, 13]. 
Revision knee arthroplasties are costly to patients, hospitals and society [13-15]. 
Compared to primary procedures, the patient satisfaction is lower and the rates of 
complications and re-revisions are higher [3, 16, 17]. To meet the increasing demand 
for knee arthroplasties, implants and surgical techniques are continuously developing. 
The effects of new implants and technology on survival, revision causes and the 
patient’s pain and function should be studied, and a close follow-up on trends over 
time is needed.  
Despite a high rate of revision-free primary TKAs, many patients experience 
dissatisfaction, pain or poor function following knee arthroplasty. In a study by 
Bourne at al., 72-86% of the patients were satisfied with their pain relief and 70-84% 
were satisfied with their function 1 year after TKA. Lindberg et al. found that 1 in 5 
patients had no improvement in pain-related interference with walking 12 months 
after TKA [18]. Additional studies report high proportions of patients with significant 
pain or dissatisfaction after TKA [19-22]. These studies show that there is still a need 
for improvement in knee arthroplasty. 
2. Alignment in total knee arthroplasty 
One of the key factors for a successful TKA is to achieve a good alignment of the 
implant and hence the limb. Implant malalignment is a frequent reason for revision 
[23]. Previous studies have found that malaligned implants have inferior implant 
survival [24-26] and poorer outcomes for pain and function [27, 28]. Many of these 
studies use a neutral mechanical axis ±3° as target for optimal alignment of the 
extremity. In a mechanically aligned TKA, the femoral and tibial components are 
positioned perpendicular to the mechanical axis of each bone. This leads to a neutral 
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hip-knee-ankle angle of the limb in static weight-bearing conditions. In a knee with a 
neutral mechanical axis, a straight line from the center of the femoral head to the 
center of talus passes through the center of the knee. A neutral mechanical axis has 
been considered by most surgeons as the optimal alignment and is often referred to as 
mechanical alignment. Implants with more than ±3° of malalignment (varus or 
valgus, see figure 1) are often termed as outliers. 
 
Figure 1. Illustration of knees with varus, neutral and valgus alignments (Elsevier 
illustration services, all rights reserved). 
 
In the general population, it is not unusual to have a malaligned knee, despite the lack 
of symptoms. Bellemans et al. found that 32% of men and 17% of women aged 20 to 
27 had varus alignment [29]. Others may have developed malalignment due to many 
years of osteoarthritis. A study of patients with preoperative varus deformity showed 
that these patients had a higher improvement in Knee Society Score after TKA if the 
postoperative alignment was left in mild varus (3-6°) compared to patients with 
postoperative neutral alignment or severe valgus (>6°) [30]. These studies indicate 
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that correction to a neutral mechanical axis is not necessarily the optimal situation for 
all patients. 
During the last decade, it has been debated whether a neutral mechanical axis is the 
correct alignment for all patients, and some researchers claim that kinematic 
alignment is a better alternative for reducing pain, stiffness and instability [31-33]. 
With kinematic alignment, the surgeon attempts to restore the patient’s pre-arthritic 
alignment in order to improve functional outcomes. In contrast to the mechanically 
aligned TKA, the native knee has an articular surface with the tibia in 3° varus and 
the femur in 2-3° valgus relative to the mechanical axis [29]. In patients with 
deformity, soft tissues and ligaments are adapted to the alignment of the patient’s 
knee. If the mechanical axis is corrected in a TKA procedure, soft tissue releases are 
often needed, and some surgeons and researchers worry that a full correction of the 
original deformity may lead to instability and poor function [31, 34, 35]. A 
randomized controlled trial by Dosset et al. showed superior flexion, Knee Society 
score and patient-reported outcomes for kinematically aligned TKA compared to 
mechanically aligned TKA [36]. However, Young et al. found no difference in 
patient-reported outcomes between kinematically and mechanically aligned TKAs at 
two years [37]. The issue of alignment is continuously debated, but mechanical axis 
is still the gold standard for most surgeons [38, 39]. 
3. Computer navigation in total knee arthroplasty 
Navigation in surgery was developed for neurosurgery in the 1990s using computed 
tomography (CT) and magnetic resonance imaging (MRI) based methods (“image-
based” navigation). The goal was to allow the surgeon to perform surgical procedures 
safer and less invasive [40]. Later, computer navigation was introduced in orthopedic 
surgery to make joint replacement more accurate and reproducible. In TKA, the main 
purpose of navigation was to improve positioning of the prosthesis components and 
the mechanical axis of the knee [41]. Development of image free navigation (“model-
based” navigation) made the procedure simpler and the patients did not need 
additional radiation exposure from CT imaging. The first in vitro image-free 
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navigated TKA was performed in 1997 by Saragaglia and Picard, and an early study 
by the same surgeons showed that the method had reliable results [42, 43]. The 
following years, Computer Assisted Surgery (CAS) was further developed, and many 
studies had promising results regarding improvement in implant alignment [44-47]. 
  
Figure 2. Photos from a CAS operation where markers with reflective beads are fixed to 
the femur and tibia (left). The computer is shown to the right. Photo: Øystein Gøthesen 
 
The CAS technology uses computer software and specific anatomical landmarks to 
create a three-dimensional system that is used to guide the surgeon to the optimal 
component positioning. During the operation, two cameras emit and register infrared 
light, which is reflected by passive reflective beads that are fixed to the femur and 
tibia (rigid bodies). A marker, also with reflective beads, is used to mark specific 
anatomical landmarks. Marks on the tibial plateau and on the ankle are used to 
calculate the center of talus and to create the tibial axis. To find the femoral axis, the 
leg with reflection beads is rotated in circles. The computer software then calculates 
the center of the femoral head by using the formula of a cone. Information of the 
patient’s anatomy is used by the computer to determine the position of the cutting 
blocks, the size and rotation of the prosthesis components and ligament balancing. 
The accuracy of the system is within 1 mm and ±1° of target for frontal and sagittal 




Figure 3. By rotating the leg, the femur forms a cone. The computer uses this 
information to calculate the center of the hip. 
 
In Norway, the use of CAS has been registered in the Norwegian Arthroplasty 
Register since 2005. During 2008-2010, the use of CAS increased to almost 20% of 
the procedures. Since 2011, CAS has been used in approximately 10% of TKAs [3]. 
This is a high proportion compared to the use of CAS in Sweden (0.1% in 2015) [11]. 
In Australia, however, 30.8% of primary TKAs were inserted using CAS in 2016, 
which is an increase from 2.3% in 2003 [9]. The variation of its use illustrates that the 




Figure 4. The use of CAS in Norway (left) [3] and in Australia (right). The curve to the right 




The role of CAS has been debated [42, 50]. Randomized trials and meta-analyses 
have concluded that CAS leads to a more accurate alignment, but the results are 
inconclusive regarding differences in PROs or implant survivorship [51-56]. 
Although mechanical alignment is preferred by many surgeons, it is not clear if CAS 
is the best method for achieving that target. Patient-specific instruments and patient-
specific implants based on CT or MRI scans have also been used to improve 
alignment and kinematics in TKA [57-59]. However, there is no evidence to suggest 
that one of these methods is superior to the other in this respect [60-65].  
CAS leads to higher costs for the clinics and a prolonged operative time for most 
surgeons. The effects on PROs and implant survivorship are also uncertain. This may 
be the reason that CAS is not widely used today, two decades after its introduction. 
This PhD project contributes to an increase in the knowledge on radiological 
outcomes, longevity of the implant and the patient’s pain, function and quality of life 
in TKAs operated with CAS compared to conventional technique (CON). 
4. Revision causes 
Furthermore, this thesis addresses the causes of revisions in knee arthroplasties as 
reported to the NAR. Theoretically, a more accurate positioning of the knee implant, 
as with CAS, may result in a better longevity of the knee arthroplasty. It is not known 
what reasons for revision are lowered by an improved positioning. Consequently, a 
registry study investigating the most common revision causes of knee replacements 
was advocated. The reasons for revision may be different for TKAs and UKAs, and 
to address the failure mechanisms in order to avoid them, a comparative analysis was 
performed.  
According to reports from large joint registries worldwide, infection and aseptic 
loosening are the most common revision causes for TKA [3, 9-11, 66, 67]. For UKA, 
most revisions are caused by aseptic loosening, progression of osteoarthritis or 
unexplained pain [3, 9, 11, 66]. Additional single- or multicentre studies have shown 
a high and increasing number of early revisions for TKA and UKA, and infection was 
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one of the major causes of early TKA revisions [23, 68, 69]. Infection is a serious 
complication after knee arthroplasty that often requires multiple revision procedures, 
and the costs are high [70].  
A previous study from the NAR showed that the risk of aseptic loosening varied 
among different prosthesis brands, and that the risk of loosening was highest for the 
tibial component for most of the included implant models [71]. In a study by Lee et 
al., tibial loosening was also more common than femoral loosening, and >3° 
malalignment of the femoral component was associated with tibial loosening [72]. 
Instability is a common cause of both early and late revisions [73, 74]. Instability can 
arise from various reasons, such as aseptic loosening, malalignment of components, 
inaccurate size of components and polyethylene wear. Female gender or a great 
preoperative malalignment may have an increased risk of instability [75, 76], but 
surgical technique, ligament balancing and implant selection also play an important 
role. Polyethylene wear is most often seen in late revisions, accounting for up to 48% 
of revisions >15 years after primary TKA [23]. It is also found a decline in revisions 
caused by polyethylene wear compared to previous studies [69, 74].  
Over the last decades, implants and surgical techniques have developed, and new 
technologies like CAS and patient-specific instruments and implants are introduced to 
improve results of knee arthroplasty. It is interesting to explore whether these 
changes over time affect the causes of revision and the occurrence of early and late 
revisions. Due to the increasing risk of revisions in general and the tendency of 
increasing early infections, it is important to investigate the reasons for revision in 
large joint registers, that have a wide range of surgeon experience and large volumes, 
leading to a high external validity.  
5. Unicompartmental knee arthroplasty (UKA)  
UKA can be used if the patient has an isolated medial or lateral osteoarthritis. In 
addition, the medial collateral ligament and the anterior and posterior cruciate 
ligaments must be intact and functional. Compared to TKA, patients with UKA have 
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a lower risk of postoperative complications, better forgotten joint score and 
marginally better patient-reported functional outcomes, but a higher revision rate [77-
80]. A systematic review comparing UKA and TKA found that the two implant types 
had similar outcomes in PROMs regarding pain, but UKA had better functional 
PROM scores than TKA [78]. A different study found that patient satisfaction is not 
remarkably different for TKA and UKA [81]. Selecting appropriate patients is 
difficult and operating UKA is a technically demanding procedure, and a low hospital 
volume is associated with higher risk of revision [82-84]. 
6. Radiostereometric analysis (RSA) and implant loosening 
Radiostereometric analysis is a precise method for the measurement of three-
dimensional migration of an implant relative to the bone and polyethylene wear. It 
was introduced in 1974 by Gunnar Selvik and a Swedish research group [85] and has 
been widely used in research for the assessment of orthopedic joint replacements. It 
has been shown, also for TKA, that early implant migration corresponds to the risk of 
loosening at mid-term [86, 87]. The method can determine a relative motion of 
approximately 0.2 mm and 0.2-1.2° [87]. Thus, few patients are needed to achieve a 
high statistical power. In 2005, Valstar et al. published guidelines for standardization 
of RSA studies, including a checklist for presentation of RSA data [88].  
In the existing literature, few RSA studies are linking migration to alignment. In a 
study by van Hamersveld et al., varus malalignment of the limb led to higher tibial 
migration at 5 years follow-up [89]. Teeter et al. found no correlation between leg 
alignment and migration at 10 years, but increasing varus alignment of the tibial 
component was associated with increasing migration [90]. Van Strien et al. compared 
RSA in CT-free and CT-based CAS compared to conventional TKA. This study 
found a higher caudal-cranial migration in the conventional group compared to CT-
free and CT-based CAS, but there was no difference in the number of outliers among 
the groups [91]. 
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A systematic review of RSA in TKA found an association between migration at 6 
months and late revision [92]. On the other hand, Molt et al. claimed that long-term 
RSA is needed to avoid overestimation of late revisions [93]. To confirm the 
association between migration and revision, studies with repeated RSA over time is 
needed.  
7. Patient reported outcomes (PROs) 
Definition 
A patient reported outcome (PRO) is defined by the U.S. Food and Drug 
Administration: “A PRO is any report of the status of a patient’s health condition that 
comes directly from the patient. The outcome can be measured in absolute terms (…) 
or as a change from a previous measure.” [94].  
Why use PROs? 
Survivorship and alignment are important end points in the evaluation of knee 
arthroplasty, as a measure of success or failure of the implant. However, these 
outcomes give no information about the patient’s function, level of pain or symptoms, 
which is highly important for the patients that undergo knee arthroplasty. The 
patient’s opinion is important in a patient-centered approach to health care [95]. 
Patients and surgeons may have different expectations to outcomes of the operation, 
and the patient’s subjective experience is important when considering whether the 
treatment was successful or not.    
Different scoring systems are used to evaluate functional outcomes and symptoms 
after TKA. The scores can be filled out by health workers or by the patient. Health 
personnel administered scores give a more objective view of the patient’s health 
condition, but are not suitable for assessing the patient’s subjective experience of the 
disease/treatment, such as pain, satisfaction and health related quality of life. For this 
purpose, the score must be filled out by the patient, without influence of health 
workers, caregivers or others. 
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Patient-administered questionnaires are often referred to as a PRO instrument or 
Patient Reported Outcome Measure (PROM) [94]. Different PROMs are used for 
measuring general health status (generic PROMs) or the status of function or 
symptoms regarding a certain condition (disease-specific PROMs). Generic PROMs 
focus on the global health status of the patient, like self-care and mobility. It can be 
used across different populations and diagnoses, and thus compare the health status of 
a knee arthroplasty patient to patients with multiple sclerosis, depression or the 
general population in a certain age group. Disease-specific PROMs contain more 
detailed questions that are relevant for a certain condition. Compared to generic 
PROMs, these measures are often more sensitive to small changes that may be 
important to patients and clinicians [96]. For example, the Knee injury and 
Osteoarthritis Outcome Score (KOOS) questionnaire contains questions relevant to 
patients with osteoarthritis or patients with knee arthroplasty; most attention is given 
to the knee pain, stiffness and tasks that challenge the knee (i.e. ascending and 
descending stairs).  
Interpretation of PROs 
Interpretation of PROs can be challenging. Different PROM scores may display 
results on different scales, and it is not straightforward to find out what level of 
improvement that represents a good outcome or a clinically relevant change. The 
clinically relevant change is often termed the Minimal Important Change (MIC). The 
Patient acceptable symptom state (PASS) is the threshold value that indicates when 
the patients feel that their condition is satisfactory after the treatment, or “the value 
beyond which patients consider themselves well” [97]. The MIC and PASS values are 
not consistent across patient populations or diagnoses. For example, a young and 
active patient that is treated for anterior cruciate ligament rupture may have higher 
demands to postoperative knee function than a 70-year old moderately active patient 
after TKA. Therefore, it is important that the level and changes of scores are 
interpreted according to the patient population in question. 
Different types of bias may influence the interpretation of PRO data. Sometimes 
patients are reluctant to select answers in the lower or upper extremes of the scale. 
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This phenomenon is referred to as end-aversion bias [98]. Ceiling and floor effects 
may occur when patients predominantly answer in the upper or lower extreme of the 
scale, indicating that the PRO instrument has limited validity for the area of interest 
in the target population [99]. Recall bias occurs when patients remember their former 
health state as better or as worse than it actually was. This can cause problems in 
cross-sectional studies when patients are asked about their current health status and 
their health status before treatment. Patients can also change their report of health 
status over time, despite that there is no change in objective circumstances. There 
may be a discrepancy in the patient’s report of PROs and their degree of satisfaction 
[100]. This phenomenon is called response shift, and could be caused by subjective 
changes in the patient’s perception of health status over time [98]. Despite the 
difficulties in interpretation of PROs, it is important to bring the patient’s perspective 
into evaluation of TKA. When researchers are aware of possible sources of bias and 
limitations, PROs represent an important contribution to increased knowledge and 
improved outcome of arthroplasty surgery. 
Aim of the thesis 
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Aim of the thesis 
The main objective of the thesis was to evaluate the mid-term effects of computer 
navigation in total knee arthroplasties in Norway, in terms of implant survival, causes 
of revision, implant migration and patient-reported outcomes. The thesis also aims to 
look at the results of computer navigation in light of the last decades’ changes in 
survival and revision causes in knee arthroplasty in Norway.  
The specific aims of each paper: 
Paper I 
 To assess the mid-term survivorship in CAS compared to CON in patients 
operated in Norway in 2005-2014. 
 To compare the risk of revision and causes of revision in CAS and CON. 
Paper II 
The aim of this paper was to answer the following questions: 
 Were there improvements in survival for TKA and UKA when comparing two 
consecutive 11-year periods with similar follow-ups in a national registry? 
 Were there changes in the causes of revision in the two time periods? 
 Could the changes in revision causes be attributed to patient or implant 
characteristics? 
Paper III 
 To compare the migration of the TKA tibial component measured by 
radiostereometric analysis (RSA) for CAS and CON at 5 years follow-up from 
a randomized controlled trial. 
 To compare the number of responders to treatment for CAS and CON based 
on patient-reported outcomes at 5 years follow-up. 
 To evaluate the improvement in patient-reported pain, function and quality of 




1. Data sources 
The Norwegian Arthroplasty Register 
The Norwegian Arthroplasty Register (NAR) was established in 1987 as a hip 
arthroplasty register [101]. Since 1994, the registration of knee arthroplasty and other 
joint replacements were included [102]. Information about the patient and the 
procedure is filled in a 1-page registration form by the surgeon immediately after 
operation and the information is stored in the NAR database. Registrations of 
revisions are linked to the primary operation by the unique 11-digit Norwegian 
personal identification number [103]. To update information on deaths and 
emigrations, the same identification number is used to link the NAR to the National 
Registry, which is Norway’s largest register of personal information [104]. The NAR 
covers a population of approximately 5.2 million, and the number of annually 
registered knee implants has increased from around 1000 in 1994 to more than 7500 
in 2018 (6905 primary operations and 648 revisions). The registration completeness 
is 97% for primary TKA and 91% for revision TKA [3, 105].  
Since 2005, the NAR has registered the use of CAS in TKA. In the registration form, 
the surgeon marks «No» or «Yes» to register the use of computer navigation. If no 
box is checked, the information on computer navigation is registered as “missing”. 
The type of navigation system is written by hand in a text-field. 
 
 
Figure 5. This detail from the NAR registration form shows registration of 
computer navigation and type of navigation system. 
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2. Outcomes and outcome measures 
2.1. Implant longevity 
Revision is a common outcome in arthroplasty register research. In the NAR, revision 
is defined as the removal, exchange, or addition of one or more prosthesis 
components (including exchange of a polyethylene insert or addition of a patellar 
component in patella non-resurfaced TKA). In arthroplasty register research, 
prosthesis survival and risk of revision is commonly calculated by the Kaplan-Meier 
method and Cox regression.  
Some patients have pain or poor function after TKA, but do not undergo revision for 
various reasons, for instance severe comorbidity or surgeon reluctance. These TKAs 
are clinical failures, but are not presented as failures in the implant survival analyses. 
A combination of different outcomes (implant survival and PROs) gives a more 
complete view on the number of failures after TKA. 
2.2. Revision causes 
Causes of revision was an important outcome in paper II and also one of the 
secondary outcomes in paper I.  
In the registration form, the surgeon marks whether the operation is a primary knee 
arthroplasty or a revision and the causes of revision. For each revision, several 
revision causes can be registered. However, if a patient had more than one revision, 
only the first revision was included in the analyses. The main cause of revision was 
determined by the hierarchy from the Australian Orthopaedic Association National 
Joint Replacement Registry (AOANJRR) [9]. Some adjustments were made to make 
the hierarchy more appropriate for revision causes registered in the NAR. In example, 
the AOANJRR uses the term “aseptic loosening” for all components whereas the 
NAR registers loosening of proximal, distal or patellar component separately (figure 
6). To be classified as a revision caused by pain, no other reason for revision could be 
registered. These revisions were termed “pain only” in paper I and “unexplained 
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pain” in paper II. Only the main cause of revision was included in the analyses of 
revision causes in paper I and II. 
 
Figure 6. This detail from the NAR registration form shows how the surgeon 
registers whether the operation is a primary operation or revision and the cause of 
the operation.  
 
The hierarchy from AOANJRR and the hierarchy used in paper I and II are provided 




2.3. Radiological evaluation 
Radiostereometric analysis (RSA)  
During the TKA implantation, 9 tantalum markers (1.0 mm in diameter) were 
inserted into the proximal tibia and 6 markers (0.8 and 1.0 mm) were inserted into the 
polyethylene component in a specific manner. The markers in each segment (bone or 
polyethylene) defined a three-dimensional rigid body. The RSA examinations were 
done with the knee in a biplane calibration cage (cage 10; RSA Biomedical, Umeå, 
Sweden). Tantalum beads in the calibration cage make out a coordinate system as a 
reference to the markers in the patient. Radiographs from the repeated RSA 
examinations are uploaded to the software used to determine the coordinates of the 
markers (UmRSA Digital Measure version 6.0, RSA Biomedical). 
 
 
Figure 7. Left: Tantalum markers with diameter 0.8 mm and 1.0 mm were 
inserted into the tibial metaphysis and the polyethylene component during the 
operation. Illustration by The Department of Photo and Illustration, University of 






Figure 8. Postoperative radiographs of a knee with RSA markers. 
 
The movements of the rigid bodies between the different examinations are used to 
calculate translation and rotation of the tibial component relative to the tibial bone. 
The three-dimensional movements of the implant were described as translation and 
rotation along and around the x-axis (medial-lateral; anterior-posterior rotation), y-
axis (distal-proximal; internal-external rotation) and z-axis (posterior-anterior; varus-
valgus rotation). Further, the maximum total point motion (MTPM) represents the 





Figure 9. Possible translation of the tibia; Maximum total point motion (MTPM), 
subsidence and lift off. 
 
The condition number (CN) and mean error of rigid body fitting (ME) were used to 
evaluate the quality of RSA measurements. The CN is determined by the number and 
three-dimensional spread of the markers, indicating the three-dimensional quality of 
the segment. If a segment has few markers, the markers are close to each other or on 
a straight line, the CN will increase. The ME describes the stability of the markers, 
expressed by the mean difference between the relative distances of markers in 
repeated examinations. Guidelines for RSA suggest 150 as a maximum value for CN 
and 0.35 mm as upper limit for ME [88], but in paper III the stricter limit of 130 for 
CN was used, as this indicate more reliable measurements.  
The repeatability of the measurements was evaluated by double examinations of the 
same patient. After one examination, the patient walks a few steps in the room while 
the RSA setup is rearranged, before an immediate repetition of the same examination. 
The expected migration of the implant between these two examinations is zero, and 
the measured migration expresses the error of the method. Limits for significant 
translations and rotations (the precision) are calculated as the 99% confidence 
intervals of the absolute mean values from analyses of the double examinations.  




For the measurement of radiolucent lines, we used the Knee Society Total Knee 
Arthroplasty Roentgenographic Evaluation and Scoring System as described by 
Ewald in 1989 [106]. Radiolucent lines were measured on radiographs in frontal and 
sagittal view at 3 months and 5 years after the operation (figure 10). 
 
Figure 10. Postoperative radiographs with radiolucent lines (marked by a yellow 
arrow) in frontal view. 
 
2.4. Patient reported outcomes (PROs) 
Paper III included PROs as outcomes. The questionnaires consisted of validated, 
widely used scores, to make the results comparable to other studies. The EuroQol 
EQ-5D and the visual analogue scale (VAS) are generic scores, whereas the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC), KOOS, 
Charnley category and Knee Society Score (KSS) are disease-specific scores for knee 
injury and osteoarthritis. We also used responder analysis that combines the results of 




EQ-5D – general health status 
EQ-5D is a self-administered, standardized measure of health, developed by the 
EuroQol Group [107]. The EQ-5D has 5 dimensions (mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression). Each dimension is divided into 3 
levels/possible responses (no problem, some problems or extreme problems). 
Reference scores are generated through a large European study [108].  
Visual Analogue Scale (VAS)  
A Visual Analogue Scale is used for issues that are more suitable to measure on a 
continuous scale rather than in categories and is considered a reliable tool for the 
estimation of the intensity of pain [109]. The scale is a horizontal line (100 mm) 
where the left end (score 0) indicates total absence of pain or complete satisfaction, 
and the right end (score 100) indicates the worst possible pain or dissatisfaction. The 
patients mark a point on the line that corresponds to their situation. The distance from 
the left end to the mark determines the VAS score. 
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 
The WOMAC score has 24 questions for assessment of pain, disability and joint 
stiffness in patients with hip or knee osteoarthritis [110]. It is widely used in the US., 
and recommended by the Journal of Bone and Joint Surgery (Am) for use in knee 
arthroplasty studies [111]. The questionnaire has 24 items and is considered valid, 
reliable and responsive to osteoarthritis outcomes [112]. Use of the WOMAC score 
requires licensing.  
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 
KOOS is a knee-specific questionnaire that was developed by a Swedish research 
group in 1995 to evaluate the patient’s opinion about their knee problems and 
treatment [113]. All questions in WOMAC are identically repeated in the KOOS 
score. Thus, WOMAC scores can be calculated from the KOOS score. In addition, 
KOOS contains questions to detect early and late disease-specific symptoms. The 42 
questions are divided into 5 subscales: Pain (9 items), Symptoms (7 items), Activities 
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of Daily Living (ADL) (17 items), Sport and Recreation Function (SportRec) (5 
items) and knee-related Quality of Life (QOL) (4 items). All items have 5 possible 
answers with scores from 0 to 4. The total score is summarized and transformed to a 
0-100 scale, with 0 indicating extreme knee problems and 100 indicating no knee 
problems. In 40 of the 42 questions, only the knee related problems during the last 
week should be considered. The two remaining questions refer to the last month. 
KOOS is validated in several populations [113, 114]. A Norwegian version has been 
approved and used in studies [115], and a description of the validation process is 
available at “http://www.koos.nu”.  
Responder analysis  
The responder analysis uses a set of criteria to determine if the patient is responding 
to the treatment. The Outcome Measures in Rheumatology – Osteoarthritis Research 
Society International (OMERACT-OARSI) set of responder criteria defines the 
patient as a responder or a non-responder according to the absolute and relative 
change of scores within three domains: pain, function and the patient’s global 
assessment [116, 117]. The patient is considered a responder if he has an 
improvement in pain or function of ≥50% and an absolute change ≥20 points. The 
patient is considered a moderate responder if he has an improvement in at least two of 
the three following criteria: 1. Pain ≥20% and absolute change ≥10; 2. Function 
≥20% and absolute change ≥10; 3. Patient’s global assessment of the disease ≥20% 
and absolute change ≥10. Patients not meeting these criteria are defined as non-
responders. 
2.5. Other knee scores 
Charnley category 
This simple classification was developed by Sir John Charnley for hip arthroplasty 
patients to facilitate assessment of the function of walking, and was later modified for 
patients with knee arthroplasty [118, 119]. The score groups patients in 3 categories 
to classify knee-specific comorbidity that may affect outcome. Category A refers to a 
unilateral knee problem, with no other conditions interfering with walking. Patients in 
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category B have problems with both knees, whereas patients in category C have an 
additional medical condition interfering with walking, such as cardiovascular or 
respiratory disability, chronic back pain or claudicatio intermittens.  
American Knee Society Score 
The Knee Society Score was developed in 1989 as a health personnel administered, 
objective scoring system for the patient’s functional abilities before and after TKA 
[120]. This scoring system is divided into a knee score (including clinical tests) and a 
function score with a maximum of 100 points each (0 worst, 200 best score). In 2012, 
a revised Knee Society Knee Scoring System was developed [121, 122]. 
3. Methodology description for each paper  
3.1. Paper I 
Study design 
Paper I is a prospective, observational registry study. The level of evidence for this 
study is III. 
Data sources 
All data in this study was collected from the NAR. Since registration of CAS started 
in 2005, we included TKAs operated from 01.01.2005 to 31.12.2014. Hinged, bi-
compartmental and patella resurfaced TKAs were excluded due to low numbers. A 
study from the NAR in 2011 compared CAS and CON at short-term follow-up with 
patients receiving a TKA in 2005-2008 [123]. In this time period, 10 different 
implants and 4 different navigation systems were used in CAS operations. Implants 
and navigation systems that were used in less than 25 procedures were excluded. 
Thus, the 5 most used prosthesis brands (AGC, Biomet; Duracon, Stryker; e.motion, 
Aesculap; LCS Complete, DePuy; Profix, Smith & Nephew) and the 3 most used 
navigation systems (Brainlab, Orthopilot and Stryker) were included. In paper I, we 
wanted to compare the results from the study by Gøthesen et al. [123], thus we 
included the same 5 prosthesis brands and the same 3 navigation systems. The same 
Methods 
 36 
prosthesis brands were also included in the CON group, leaving 3665 computer 
navigated and 20,019 conventionally operated knees that were eligible for evaluation. 
Statistics 
The null hypothesis for this study was that there was no difference in survival or 
relative risk of revision (RR) in TKAs operated with CAS or CON. Also, we wanted 
to study the relative risk of revision for CAS compared to CON in subgroups of the 
different prosthesis brands, fixation methods and in patients more or less than 65 
years of age. We also wanted to study whether the groups differed in the risk of 
revision due to each of the registered revision causes and if there was a learning curve 
on hospital level. 
Differences in baseline characteristics of the groups were calculated by Pearson’s Chi 
square test and Student’s t-test. Reverse Kaplan-Meier was used to calculate median 
follow-up [124]. The relative risk of revision for CAS relative to CON was tested in a 
Cox regression model, adjusted for age (continuous), sex (male/female), prosthesis 
brand (Profix as reference), The American Society of Anesthesiologists (ASA) 
category (1/2/3+), fixation method (cemented/uncemented/hybrid (uncemented 
femur, cemented tibia)), diagnosis (osteoarthritis/other) and previous surgery of the 
knee (yes/no). The proportional hazard assumption was assessed by visual inspection 
of log-log-plots. To ensure that deaths and emigrations did not affect the results, this 
was tested in a competing risk model [125]. The robustness of the analysis was 
investigated by a simpler Cox regression model adjusted for age, sex and diagnosis. 
We also did a Cox regression analysis with adjustment for a propensity score, in 
order to add more covariates to the model. The propensity score included the same 
covariates as the Cox regression model above, in addition to side (left/right), 
peroperative complications (yes/no), deficiency of anterior cruciate ligament 
preoperative (yes/no) and deficiency of posterior cruciate ligament preoperatively and 
postoperatively (yes/no).  
Implant survival was defined as the time from the primary operation to the first 
revision. Implant survival was estimated by Kaplan-Meier analysis at 5 and 8 years 
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postoperative, with censoring at time of death, emigration or at the end of the study 
period (31.12.2014). The NAR was linked to the National Registry to obtain 
information about deaths and emigrations. 
Possible effects of a learning curve were investigated by analyzing the first 30 
procedures that were done in each hospital, since the learning curve was shown to 
stabilize after 30 procedures [126, 127]. Differences in operation time were tested by 
Mann-Whitney tests because the operation time was not normally distributed.  
All tests were 2-sided and the significance level was 0.05.  
3.2. Paper II 
Study design 
This paper is a prospective, observational registry study. The level of evidence is III.  
The study was designed to answer the following research questions: (1) Were there 
improvements in survival for TKA and UKA when comparing two consecutive 11-
year periods with similar follow-ups in a national registry? (2) Were there changes in 
the causes of revision in the two time periods? (3) Could the changes in revision 
causes be attributed to patient or implant characteristics? 
Data sources 
The NAR was the only data source for this study and primary knee arthroplasties 
reported between 01.01.1994 and 31.12.2015 were included. Hinged, 
bicompartmental and patellofemoral joint replacements were excluded due to low 
numbers and to ensure a more homogenous study population. For patients that were 
revised during the time of follow-up, only the first revision was accounted for in this 
study. If multiple revision causes were reported, the main cause of revision was 
determined based on the hierarchy from the AOANJRR [9]. In total, 60,623 TKAs 
(2426 revisions) and 7648 UKAs (725 revisions) were selected for analysis. 99.6% of 
the patients were accounted for at the time of analysis, whereas 0.4% had moved 
abroad. The included patients were divided into two time periods, based on the time 
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of the primary operation; from 1994 to 2004 (Period 1) and 2005 to 2015 (Period 2). 
In period 1, there were 17,404 TKAs and 2297 UKAs. Period 2 had 43,219 TKAs 
and 5351 UKAs.  
Statistics 
TKAs and UKAs were analyzed separately, but the same methods were used for both 
prosthesis types. To ensure that both periods had a maximum follow-up of 11 years, 
the arthroplasties in period 1 were censored 13.12.2004, whereas the arthroplasties in 
period 2 were censored 31.12.2015. Median follow-up was estimated by the reversed 
Kaplan-Meier method.  
Overall implant survival was found by a Kaplan-Meier analysis with 10 years follow-
up in each group, with censoring at time of death, emigration or at the end of follow-
up. Differences in survival between period 1 and period 2 was calculated by the log-
rank test, and an unadjusted Cox regression model was used to find a risk estimate. 
For each revision cause, a Cox regression model was used to calculate the relative 
risk of revision in period 2 relative to period 1, adjusted for age (continuous), sex, 
diagnosis (osteoarthritis/other), fixation (cemented/uncemented/hybrid), and use of 
patellar component for TKA (yes/no).  
The proportional hazard assumption (PH) was tested for overall survivorship and for 
each revision cause for TKA and UKA by statistical tests and visual inspection of 
Schoenfeld residuals [128]. If PH failed, the follow-up was divided into time intervals 
individually for each revision cause until PH was fulfilled. The cut-off points for each 
time interval was decided based on inspection of the Schoenfeld residuals and 
statistical tests [129]. 
All tests were two-sided and the statistical significance level was 0.05. The statistical 
analyses were performed by IBM Statistics Version 22.0 (IBM Corporation, Armonk, 
NY, USA) and R Version 3.3.0 (The R Foundation, Vienna, Austria). 
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3.3. Paper III 
Study design 
Paper III is a 5-year follow-up from a multicenter, randomized controlled trial that 
was conducted in 2009-2011. The level of evidence is I for this study.  
Intervention 
192 patients were randomly parallel-group assigned to undergo TKA with either CAS 
or CON (allocation ratio 1:1). To ensure an equal number of patients in the two 
treatment groups, a computer generated block randomization for each of the involved 
surgeons was used, with randomly varying block sizes of two and four. The patients 
were included and operated at four different hospitals in Norway; Haukeland 
University Hospital (public, Bergen), Lovisenberg Diakonal Hospital (private non-
profit, Oslo), Haugesund Hospital (public, Haugesund) and Haugesund 
Sanitetsforening’s Hospital (private non-profit, Haugesund) and eight surgeons 
performed the knee arthroplasties. Before start-up of the study, all the surgeons had 
done at least 100 TKAs with CON and 10 TKAs with CAS. All patients received a 
cruciate retaining Profix knee prosthesis (Smith & Nephew, Memphis, Tennessee), 
cemented with Palacos R+G (Heraeus, Hanau, Germany). The navigation system 
used in the CAS group was the VectorVision knee software version 1.6.93616 with 
the Kolibri system from BrainLab (Munich, Germany). To ensure blinding of the 
patients, two sham incisions were made over midshaft tibia for the CON patients to 
mimic the stab incisions for the CAS patients.  
The first 54 included patients were operated with RSA markers. During the operation, 
six tantalum-sphere markers (diameter 0.8 mm and 1.0 mm) were inserted into the 
polyethylene component, whereas nine markers (diameter 1.0 mm) were inserted in 
the tibial metaphysis before cementing. The index RSA examination was taken within 
one week after insertion. The RSA examinations were sent to the RSA-lab at the 
Orthopedic Research Center at Trondheim University Hospital for analysis. All 
patients received the same antithrombotic and antibiotic medication and a 
standardized exercise program was carried out for the patients postoperatively. 
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Scheduled follow-up examinations for all included patients were at 3, 12, 24 months 
and 5 years after operation. The follow-up consisted of radiographs (front and side 
view) of the operated knee (patients with RSA markers had RSA examinations 
according to the RSA protocol), a clinical examination including KSS and a self-
administered questionnaire (KOOS, VAS-pain and EQ-5D). The clinical 
examinations were done by trained physiotherapists who were blinded to treatment 
group. 
Inclusion 
The age criterion was initially 60-80 years, but was expanded to 50-85 years 6 
months after the start of inclusion due to a slow recruitment rate. Eligible patients for 
inclusion were men and women aged 50-85 years in need of a total knee replacement 
due to osteoarthritis or arthritic disease of the knee, within ASA category 1-3. 
Exclusion criteria were severe systemic disease, severe neurological disorder, a 
history of cancer, dementia, body mass index (BMI) > 35 kg/m2, previous fractures of 
the shaft of tibia or femur, severe valgus position of the knee (>15° from the 
mechanical axis of the knee), previous osteotomy of the tibia or femur, recent knee 
injury (less than one year pre-operatively), severe stiffness of the ipsilateral hip, 
ipsilateral hip replacement and allergy to metals. If a patient needed two knee 
replacements, only the first knee evaluated in the recruitment period was included in 
the trial. 
Statistics 
The study was divided in two parts; all the included patients were assessed on PROs 
and postoperative alignment. A sub-group of patients also received RSA markers for 
the evaluation of implant migration. The 1-year follow-up of the patients was 
published in 2014 by Gøthesen et al., with KOOS pain score as primary outcome and 
additional PROs and postoperative alignment as secondary outcomes [53]. At 2 years 
follow-up, migration of the implant was the primary outcome, whereas PROs were 
secondary outcomes [130, 131]. 
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The primary outcome in this study was migration of the implant 5 years after primary 
TKA, measured by RSA. Secondary outcomes were mean changes of PROs from 
preoperative to 5 years (KSS, KOOS, EQ-5D and VAS for pain), the proportion of 
responders according to the OMERACT-OARSI criteria and the occurrence of 
radiolucent lines. To calculate sample size, we used the minimal important change of 
KOOS, which is 8-10 units [113]. With a standard deviation of 20, a statistical power 
of 80% and significance level of 0.05, we needed 64 patients in each group. To 
account for deaths and lost to follow-up, we included a total of 192 patients (97 CAS, 
95 CON). For the RSA part of the trial, we assumed that 0.1 mm was a clinically 
relevant difference between the groups. The repeatability of the RSA measurements 
is 0.1 mm, measured from double examinations. To achieve a power of 80% and 
significance level 0.05, we needed 17 patients in each group. Due to the risk of drop-
outs or technical difficulties during measurements we included 54 patients in the RSA 
study (26 CAS, 28 CON). 
The groups were analyzed as intention to treat. The normality assumption was 
controlled by the Kolmogorov-Smirnov test and Shapiro-Wilk test. Differences in 
demographic variables between CAS and CON were calculated by Pearson’s chi-
square test for proportions and Student’s independent sample t-test for mean values. 
RSA data for migration were not normally distributed. The median difference in 
migration and corresponding 95% CI for the median difference in migration was 
calculated according to Campbell and Gardner [132]. Amongst the 24 measured PRO 
dimensions, 9 were not normally distributed. Due to the high number of patients 
(n≥70 for all measurements), we used the Student’s t-test in the tables presented in 
the article. The differences in PRO measures were also done by Mann-Whitney U 
test, and the results from parametric and non-parametric tests were comparable.  
All tests were two-sided and the significance level was 0.05. For the statistical 
analyses, SPSS Statistics software (version 23; Armonk, NY: IBM Corp) was used. 
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4. Ethical approval 
Paper I and paper II used data from the NAR, which has concession from the 
Norwegian Data Inspectorate to collect patient data, based on a written consent from 
the patient (last issued 15 September 2014, ref.no: 03/00058-20/CGN).  
Paper III was approved by the Regional committee for medical and health research 
ethics (REK Vest), Bergen September 29, 2007 (ref.no: 2007/12587-ARS). It was 
registered in the trial database ClinicalTrials.gov, which is a service from the United 





Paper I  
Patient characteristics 
Median time of follow-up was 5.3 years for CAS and 5.0 years for CON. The CAS 
group had a higher proportion of men, the mean age was 1 year younger and the 
patients had a lower mean ASA score compared to the CON group. The CAS group 
had a higher frequency of uncemented prostheses, previous surgery of the knee and 
preoperative deficiency of the anterior cruciate ligament. Of the 65 hospitals 
included, three hospitals had a total CAS volume of >200 TKAs from 2005 to 2014 
and 33 hospitals had a total CON volume of >200 TKAs. 
Survivorship 
The 8 years Kaplan-Meier survival rate was 94.8% (CI: 93.8-95.8) for CAS and 
94.9% (CI: 94.5-95.3) for CON. There was no statistically significant difference in 
the risk of revision for CAS relative to CON (table 1). The simple Cox regression 
model, the propensity score adjusted Cox regression model and the competing risk 
model showed small variations in the RR estimate, but there was no statistically 
significant change between CAS and CON. 
Test Overall RR (95% CI) RR <65 years (95% CI) 
Cox with many covariates* 0.8 (0.7-1.0) 0.8 (0.6-1.1) 
Simple Cox model** 0.9 (0.8-1.1) 0.9 (0.8-1.2) 
Propensity score adjusted 0.8 (0.7-1.1) 0.8 (0.6-1.1) 
Competing risk 0.9 (0.8-1.2) 0.9 (0.8-1.2) 
Table 1. This table shows the relative risk of revision (RR) for CAS relative to CON 
for all the included patients and for patients <65 years of age, calculated in different 
statistical models. *Adjusted for age, sex, prosthesis brand, ASA classification, 





For patients older or younger than 65 years of age, there was no statistically 
significant difference in the risk of revision for CAS relative to CON. Further 
analyses showed no significant difference between CAS and CON in subgroups of 
cemented, uncemented and hybrid implants or for each of the included prosthesis 
brands. When we compared the 30 first CAS procedures (learning group) to the entire 
CON group, there was no statistically significant difference in risk of revision for 
CAS relative to CON (RR=1.1; CI: 0.7-1.5).  
Median operating time was 11 minutes (p<0.001) longer for CAS when all implants 
were included and 21 minutes (p<0.001) longer for cemented implants. Deep 
infection and aseptic loosening was the most common revision causes. For CAS 
patients <65 years, instability was the most common revision cause. Patients in the 
CAS group had significantly fewer revisions due to malalignment with RR=0.5 (CI: 
0.3-0.9) for the entire group and RR=0.3 (CI: 0.1-0.8) for age <65 years.  
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Paper II  
Survivorship free from revision 
For TKAs, the 10-year Kaplan-Meier survival free from revision improved from 
Period 1 to Period 2 from 91% (CI: 90%–92%) to 94% (CI: 94%–95%; p< 0.001). To 
fulfill the proportional hazard assumption, the follow-up was split into four intervals 
and a risk estimate between the two time periods was calculated for each time 
interval: The first 1.5 months after the operation, there was a higher risk of revision in 
period 2 relative to period 1 (RR=2.8, CI: 1.9-4.0). At more than 6 months 
postoperatively, period 2 had significantly lower risk of revision with RR=0.6 (CI: 
0.6-0.7) from 0.5-6 years and RR=0.3 (CI: 0.2-0.4) from 6-11 years. 
With UKAs, the 10-year survival free from revision was 80% (CI: 76%–84%) in 
Period 1 and 81% (CI: 79%–83%; p = 0.261) in Period 2. The relative risk of revision 
in period 2 relative to period 1 was 0.9 (CI: 0.8-1.1).  
Changes in revision causes 
For TKA, revisions resulting from aseptic loosening of the femoral component, 
polyethylene wear/breakage, patellar dislocation, and unexplained pain decreased 
from period 1 to period 2. There was an increase in revisions resulting from infection 
within the first 6 months, with the highest risk the first 6 weeks (RR=5.1; CI: 2.9-
8.9). At more than one year postoperatively, the risk of revision due to infection was 
decreased in period 2 (RR=0.6; CI: 0.4-0.8). 
UKA had a decrease in revisions resulting from aseptic loosening, polyethylene 
wear/breakage, and periprosthetic fractures, but there were more revisions resulting 
from progression of osteoarthritis (RR=5.0; CI: 1.8-13.7). 
Changes in patient and implant characteristics 
Patients receiving TKA were younger and more often men in period 2 compared with 
patients in Period 1. A higher risk of revision was found for male sex (RR=1.1; CI: 
1.0–1.2) and age younger than 65 years (RR=1.7; CI: 1.6–1.9). From period 1 to 
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period 2, there was an increase in patella non-resurfaced implants, uncemented and 
hybrid fixation and the use of mobile bearing implants. 
For UKAs, period 2 had more men and the average age was younger than for patients 
in Period 1. Patients with age younger than 65 years had a higher risk of revision 
(RR=1.7, CI: 1.5–2.0), whereas sex did not affect the risk of revision. Only 66 
implants were uncemented, and all were operated in period 2. The Oxford® Phase 3 
was the most used implant in both periods (61% in period 1, 70% in period 2).  
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Paper III  
Description of the study groups 
160 patients participated in the 5 years follow-up (82 CAS, 78 CON). 42 of these 
patients had RSA markers, 21 in each group. The groups were similar in mean sex, 
mean age, BMI, diagnosis and side of the operation. 
RSA and radiolucent lines 
From 3 months to 5 years, CAS and CON did not differ significantly in rotation, 
MTPM, subsidence or lift-off. Median difference in MTPM between CAS and CON 
from 3 to 60 months was 0.13, but the difference was not statistically significant 
(p=0.14). The CAS had higher migration than the CON group from 24 to 60 months, 
but this difference was not statistically significant. Five patients had MTPM of more 
than 1.0 mm, four of these were in the CAS group. 
More than 95% of the 160 patients had less than 4 mm total width of radiolucent lines 
at 3 months and 5 years. No patients in either group had more than 10 mm total width 
of radiolucent lines in any measurement, and the groups did not differ significantly in 
the number of patients with radiolucent lines more than 4 mm. 
Patient-reported outcomes 
The mean improvement from preoperative to 5 years was higher in the CAS group for 
all PRO subscales, but the differences were not statistically or clinically significant. 
The CAS group had more patients achieving highest possible score than the CON 
group for all PRO subscales, except from the WOMAC stiffness score. 
Of the included patients, 150 (79 CAS, 71 CON) had completed enough questions in 
the questionnaire to calculate WOMAC scores, and were thus included in the 
responder analysis, according to the OMERACT-OARSI criteria. The CAS group had 
a higher proportion of high responders (n=66, 83%) compared to the CON group 
(n=52, 73%), but the difference was not statistically significant (p=0.3). The CAS 
group had statistically significant more patients meeting the criteria for high 
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responders in pain score compared to the CON group (p=0.04). The number needed 




5. Methodological considerations 
1.1. Study design 
The papers in this thesis have two different study designs; paper I and II are registry 
studies (cohort studies), whereas paper III is a randomized controlled trial. 
Registry study (paper I and II) 
The patients in paper I and paper II were included from the NAR; a nation-wide 
arthroplasty register. The data represents patients from all parts of the country and 
include many different surgeons and hospitals, varying in tradition and experience. 
Consequently, the external validity of registry studies is high, and the results 
represent the outcome for an average surgeon in Norway. Compared to RCTs, the 
level of evidence is lower. The data from a registry study can be used to find 
associations between exposure and outcome, but not to claim causality [133].  
Patients included in the NAR are diverse and have a large number of different 
diagnoses and prostheses. When designing a registry study, some groups of patients 
need to be excluded to make the results relevant for the group of patients that we 
want to study. In paper I and II, we excluded patients with hinged, bicompartmental 
and patellofemoral prostheses. These patients represent a sub-group with different 
indications and prognosis (i.e. cancer), and exclusion of these patients will make the 
results more relevant to the average knee arthroplasty patient. On the other hand, 
exclusion of too many patients decreases the external validity. In example, a study 
from the New Zealand joint registry (NZJR) compared CAS and CON, only 
including Triathlon prostheses [56]. These results are not necessarily transferable to 
other prosthesis brands, as different revision rates and revision causes are observed 
for different implants [71].  
In paper I, we wanted to compare the results to the short-term follow-up of CAS from 
2011 [123]. For this reason, we included the same prosthesis brands, which were the 
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5 most used brands from 2005-2009. The use of prosthesis brands has changed over 
time, and some of the included prosthesis brands are no longer in use in Norway [3]. 
Thus, the results are not necessarily valid for the prostheses that are used today. Still, 
we wanted to study the longest possible follow-up in our data. By including the most 
frequently used prosthesis brands, we avoided that results from low-volume brands 
(or brands that had a low CAS volume) influenced the results.  
Paper II compared two consecutive time periods, focusing on time trends in survival 
and causes of revision. The patients operated in period 1 had time of follow-up up to 
22 years in the registry (from 01.01.1994 to 31.12.2015), and we censored the 
patients in period 1 at 31.12.2004 to make the time of follow-up more similar. A 
similar follow-up is especially important in a study comparing revision causes, since 
early and late revisions differ in type of revision cause [23, 69, 134]. In paper II, 
median follow-up for TKA was 3.5 in period 1 and 4.2 in period 2. For UKA, median 
follow-up was 2.7 years in period 1 and 4.6 years in period 2. The incidence of TKA 
and UKA has increased remarkably since 1994, and the early portion of period 1 had 
few TKAs and UKAs compared to the early portion of period 2. Consequently, 
median follow-up was longer in period 2 for both TKA and UKA.  
Randomized, controlled trial (paper III) 
Paper III is a 5 years follow-up from an RCT. The study was conducted in 2009-2011 
as a large project evaluating the short- and long-term effects of CAS compared to 
CON, with angle measurements on radiographs and CT-scans, RSA analyses and 
PROs. Results from 3 months, 1 year and 2 years follow-up are previously published 
[53, 130, 131]. The outcomes, inclusion- and exclusion criteria were registered in 
ClinicalTrials.gov before start of inclusion.  
An RCT is considered the best study design to find causal relations between exposure 
and outcome. The patients are randomly assigned to treatment group, and the risk of 
bias and confounding factors is low. An important limitation of RCTs is that the 
study often includes a limited subgroup of patients that receive a treatment in clinics 
with a close follow-up by highly engaged doctors. In that case, the external validity is 
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low compared to larger studies that include a more diverse patient group. In addition, 
RCTs are often underpowered to study rare events like revision. 
1.2. Data quality 
Strengths and limitations of the NAR 
The NAR started the individual registration of knee implantations in 1994, and has a 
long follow-up compared to other joint registries worldwide. The high registration 
completeness increases the applicability and external validity of the data. If a study 
has a high external validity, the results of the study can be generalized to other patient 
groups or situations [135]. Applicability means that the effects observed in a study is 
reflecting the expected results if the intervention or treatment was used in a large 
population under “real-world” conditions [136].  
Patients in NAR are identified by the Norwegian personal 11-digit identification 
number, which ensures a correct registration of age and sex, and also a correct 
linkage between primary operation and revision. The same identification number is 
used to link the NAR to the National Registry, to get a complete follow-up of deaths 
and emigrations. The NAR is also linked to the Norwegian Patient Registry (NPR) 
for validation of registered operative procedures, which is used to calculate 
registration completeness of primary operations and revisions. However, the codes 
for inclusion in NPR and the NAR are not identical. This complicates the calculation 
of registration completeness, (especially for revisions, which include many different 
procedures and codes). A previous validation study showed that infections often are 
underreported to the NAR [137]. One explanation could be that infections are more 
frequently revised out of scheduled operating hours and thus are more easily 







NGC0* Secondary implantation of partial prosthesis in knee joint not using cement 
NGC1* Secondary implantation of partial prosthesis in knee joint using cement 
NGC2* Secondary implantation of total prosthesis in knee joint not using cement 
NGC3* Secondary implantation of total prosthesis in knee joint using hybrid technique 
NGC4* Secondary implantation of total prosthesis in knee joint using cement 
NGC99 Other secondary prosthetic replacement in knee joint 
NGU0* Removal of partial prosthesis from knee joint 
NGU1* Removal of total prosthesis from knee joint 
Table 2. This table shows NCSP procedure codes for combining data from NPR 
hospital stays and the NAR. The table is provided from the NAR annual report [3]. 
 
Stickers from the implant packaging are attached to the registration form and punched 
into the NAR database to ensure a correct registration of implants with specific 
catalogue numbers. Separate studies are done to validate data on operation date, 
diagnoses and registration completeness [137, 138]. Validation of registration 
completeness of hip and knee arthroplasties in NAR was done for the period 1999-
2002 by Espehaug et al., with linkage to the NPR [105]. Since 2008, validation of 
registration completeness has been updated every second year and the results are 
published in the annual report [3]. Most validation studies from NAR include data 
from hip arthroplasties. The registration form for hip and knee arthroplasties are quite 
similar, and the routine for registration of data by specially trained secretaries at the 
NAR is the same for hip and knee arthroplasties. Thus, we assume that the results 




Revision is a common outcome in studies using data from arthroplasty registers, and 
revision of any cause was also the main outcome in paper II. Due to the high 
registration completeness of revisions in NAR, revision is considered as a valid 
outcome. Revision as an outcome is successfully used to calculate longevity of an 
implant. Still, revision does not tell the whole truth; a patient with an unrevised TKA 
does not necessarily have a good clinical outcome or satisfactory radiographs. 
Patients with poor knee function or pain after TKA may remain unrevised due to 
concomitant diseases, a high risk of complications or reluctance by the surgeon 
towards revision surgery. A study by Murray et al. found that survival was 72% at 7 
years with moderate pain as the end point for the AGC implant. This compared to 
97.5% with revision as the end point [139]. If pain and dissatisfaction of the knee 
implant is defined as a failure, the true number of failures in Norway is unknown. 
Collection of PROs in the NAR will hopefully increase knowledge about the patients’ 
pain and satisfaction in the future.  
There may also be patients that are unnecessarily revised. In example, a patient with 
unexplained knee pain may undergo revision although the pain is caused by other 
reasons than the knee arthroplasty. In paper II, unexplained pain was a common cause 
of revision for both TKA and UKA. Previous studies have pointed out that patients 
with painful TKAs should be evaluated systematically using diagnostic algorithms, 
and conservative treatment is recommended if there is no specific manageable 
explanation for the knee pain [140-142].  
Although the NAR has high registration completeness for primary operations and 
revisions, the registration completeness and accuracy of some other variables are 
unknown. Registration of prosthesis components and cement is done by punching the 
catalogue numbers from the stickers from the manufacturer. The stickers are attached 
to the registration form by the surgeon. All prosthesis components that are in use in 
Norway are pre-registered in the database, and unknown numbers are declined by the 
system to control for punching errors. Hence, we assume that the registration of 
components is correct. 
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Causes of revision are registered by the surgeon performing the revision procedure. 
Each surgeon may classify revision causes differently, based on subjective 
assessments, personal awareness to a specific revision cause or local traditions 
(misclassification bias). In example, a loose implant in a malaligned knee may be 
classified as aseptic loosening by one surgeon and malalignment by another. 
Misclassification of revision causes is more likely to occur for revision causes that 
have an unclear definition, like instability or arthrofibrosis. Awareness of these 
revision causes typically fluctuates over time. Changes in the number of revisions 
from one time period to another, like in paper II, could be influenced by different 
classification rather than a change in patients or implants. A more accurate definition 
of the different revision causes will reduce the error of misclassification. 
Register studies use the registered patient information to adjust for possible 
confounding from age, sex and other relevant variables. Still, some important 
confounding factors like BMI, diabetes, smoking status, degree of knee stability or 
radiologic measures are not registered in the NAR and cannot be accounted for in the 
statistical analyses.  
Radiological outcomes 
RSA is the most precise method for the measurement of migration of implants in situ. 
This means that a low number of patients in each treatment arm is needed. Within our 
defined limits of significant migration, there was no difference between the groups. 
The predictive value of migration with respect to survival of the implant, will depend 
on the extent of migration. There is no hard evidence to define a predictive cut-off 
value for any migration vector. However, there are suggestions that MTPM at 1 year 
of 0.54 mm-1.6 mm is considered “at risk”, whereas MTPM above 1.6 mm is 
“unacceptable” [143]. The migration pattern applies to a group of patients with 
similar implants, and is not applicable to individual patients. Individual patients vary 
with respect to bone quality, weight, size and fit of the implant, activity, comorbidity 
etc., hence the migration patterns will differ within the group. 
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Further, RSA is believed to be a proxy for loosening at mid-term follow-up; this has 
been shown in a small number of papers on TKA [87, 92, 143]. The literature on this 
point is not overwhelming, and the real risk of loosening can only be found by long 
term follow-up in register studies. 
PROs 
To measure PROs in paper III, we used validated and widely used scores that also 
had been used in previous Norwegian studies [115, 144]. We used the KOOS 
guidelines and KOOS scoring instructions in order to make a correct calculation and 
presentation of the KOOS results [145]. A limitation with the questionnaire is that we 
did not include any anchoring questions for determination of the proportion of 
patients that were satisfied with the treatment and the proportion of patients that 
considered their treatment as a failure. In the literature, patient satisfaction is often 
termed “Patient acceptable symptom state” (PASS) [117, 146]. Ingelsrud et al. 
collected this information from patients with anterior cruciate ligament reconstruction 
[147]. In addition to the KOOS questionnaire, the authors asked: “Considering your 
knee function, do you feel that your current state is satisfactory?” This could be 
answered by “yes” or “no”. If this question was answered by “no”, the patient was 
also asked “If you answered NO to the former question, would you consider your 
current state as being so unsatisfactory that you think the treatment has failed?”; also 
to be answered by “yes” or “no”. If we had this information, we could have identified 
the proportion of patients that were satisfied with the treatment and how patient 
satisfaction corresponded to the different PRO scores included in the studies.  
A recent study by Connelly et al. has suggested PASS for KOOS in patients 
undergoing TKA, with patient-reported satisfaction as anchor [148].  The authors 
suggested PASS thresholds at 1 year and at 3 years for each KOOS subscale, except 
from KOOS SportRec (because it was considered less applicable to TKA patients). 
This study was not available when paper III was submitted, but the numbers of 
patients above PASS for CAS and CON are compared in table 3. The table shows that 
CAS has more patients above PASS in all KOOS subscales, but the difference is not 
statistically significant from CON. However, a box plot in the article by Connelly et 
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al. shows that there is a large overlap in KOOS scores for patients that are categorized 
as satisfied or dissatisfied. This illustrates that the interpretation of PROMs is 
complex, and it is difficult to predict satisfaction from scores in pain and function. As 
pointed out by Nilsdotter et al., satisfaction is also influenced by the patient’s 




at 3 years 
(Connelly et al.) 
CAS 










Pain 87.5 70% 59% 0.1 
Symptoms 84.0 57% 47% 0.2 
Activities of 
daily living 
87.5 67% 57% 0.2 
Quality of life 66.0 49% 42% 0.3 
*Pearson’s Chi square test 
Table 3. This table presents the PASS thresholds at 3 years for each KOOS subscale 
[148]. The proportion of patients with score above threshold at 5 years for CAS and 
CON is compared for each KOOS subscale. 
 
We used responder analysis to measure treatment success in paper III. We calculated 
the number of responders by the OMERACT-OARSI criteria, based on 
improvements in WOMAC scores for pain and function and EQ-5D quality of life. 
The responder analysis does not directly measure the patient’s level of satisfaction, 
but uses a certain improvement in pain and functional scores to define treatment 
response. Consequently, a patient with a high treatment response is not necessarily 
satisfied, and a patient with a low treatment response could still be satisfied. A 
responder analysis was not included in the 1-year follow-up of the RCT, published by 
Gøthesen et al. [53]. This study compared PROs by mean differences in each 
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category. The minimal important change (MIC) for KOOS is considered to be 8-10 
units [113, 145]. If the mean change between CAS and CON exceeded this 
difference, it was considered a clinically significant difference among the groups. The 
last years, it has been clearer to researchers that the MIC value should be used to 
measure differences before and after a treatment in the individual patient, and that the 
MIC value is not applicable to group comparisons [146, 150, 151]. MIC values also 
vary between different patient groups and treatments, and the MIC for KOOS in 
young patients after anterior cruciate ligament reconstruction is not similar to MIC 
for KOOS in patients undergoing TKA [152].  
As recommended by Ewa Roos [151], we considered responder analyses to be more 
appropriate to compare the difference in PROs with CAS and CON. This was done at 
two-year follow up [130] and also in paper III. The use of responder analysis could be 
challenging, because the power of the study could be reduced and the cutoff value for 
a responder may be unclear [153]. In paper III, we used the terms “high responder”, 
“moderate responder” and “non-responder” to divide treatment response into three 
groups. The issue of cutoff values and power should be considered when interpreting 
the results.  
1.3. Statistical methods 
Survival and competing risk 
In paper I and II, we used Kaplan-Meier curves and log-rank test to find differences 
in survival. Kaplan-Meier is a non-parametric method that illustrates the unadjusted 
implant survival in the two groups. In other words, it shows the net failure, which is 
the number of revisions assuming that no patients die or emigrate during follow-up 
[154]. To account for non-informative censoring, we used a competing risk model 
[125]. The competing risk model estimates the crude failure, which is the number of 
revisions in practice (since dead patients do not undergo revision) [154]. Estimates of 
the Cox regression model and the competing risk model are quite similar if the rate of 






Figure 11. Example of Kaplan-Meier survival curve, illustrating survivorship of 
unicondylar knee arthroplasties from the Norwegian Arthroplasty Register, annual 
report 2018.  
 
In paper I, the rate of deaths was 8.5 % in the CAS group and 10.4 % in the CON 
group and the rate of emigrations was 0.4 % in both groups (table 4). The difference 
in rate of deaths was statistically significant and the survival rates was further 
investigated in a competing risk model. However, the risk estimates of the competing 
risk model and the adjusted Cox regression models did not differ significantly, and 
we therefore assume that the number of deaths had a minor effect on the risk 
estimates.  
  
Patients with a revised 
prosthesis 
Patients either 
with an intact 
prosthesis, 




 CAS, n (%) CON, n (%) P value 
Alive at censoring 3338 17861  
Dead 311 2084 <0.001 
Emigrated 16 74 0.6 
Table 4. The number of deaths and emigrations for paper I is shown. P-values 
represent comparison with the number of patients alive at censoring (Pearson’s Chi-
Square test). 
 
A similar competing risk model including deaths and emigrations was also used in 
paper II in estimation of changes in survival from period 1 to period 2. The estimated 
RR of revision was similar in the competing risk model and the Cox regression model 
both for TKA and UKA.  
We presented the Kaplan-Meier survival and the Cox estimates as the main findings, 
because it presents the risk of revision assuming that the patient is still alive. This is 
the most relevant risk estimate for orthopedic surgeons and patients, and is 
considered preferable in arthroplasty register research [128, 155, 156]. A competing 
risk model could be appropriate in long-term follow-up or in cohorts of elderly or 
frail patients (such as hip fracture cohorts), which is not the case in our studies. 
Factors that affect the survival rate 
In paper I, the relative risk of revision for CAS relative to CON was calculated in a 
Cox regression model adjusted for age, sex, ASA category, prosthesis brand, fixation 
method, previous surgery and diagnosis. These covariates were included in the model 
because they were considered clinically relevant. With a high number of covariates, 
there is a risk of overadjustment bias. Overadjustment bias is defined as “control for 
an intermediate variable (or a descending proxy for an intermediate variable) on a 
causal path from exposure to outcome” [157]. We know from previous studies and 
reports that prosthesis brand and fixation method affect the revision rate [3, 71]. 
Table 1 in paper I showed that CAS had more prostheses with uncemented fixation 
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and the distribution of prosthesis brands was different in CAS and CON. Thus, the 
use of CAS (exposure) affected the choice of fixation method and prosthesis brand, 
which secondly affected the revision rate, as shown in the directed acyclic graph 
(DAG) 1 (figure 12).  
 
 
Figure 12. DAG 1. 
 
In paper II, both TKA and UKA had more men in period 2, and the mean age was 
lower compared to period 1. The covariates age and sex are known to affect revision 
rate [158, 159]. In addition, the age and sex of the patient may affect the choice of 
prosthesis brand and fixation method. In this case, age and sex are confounders that 
have an effect on both the mediator and the outcome, illustrated in DAG 2 (figure 
13). By adjusting for only age and sex in DAG 2, we find the total effect of having a 
TKA or UKA in period 2 compared to period 1. If we only adjust for the mediators, 
we open the pathway through the confounders and the effect of CAS on revision 










Figure 13. DAG 2. 
 
To address the issue of overadjustment, we made an unadjusted survival estimate by 
Kaplan-Meier and Log-rank test (paper I and II). In paper I, we also performed 
simple Cox regression analyses adjusted only for age, sex and diagnosis; factors that 
were unlikely to have a mediating effect. In addition, we used a Cox regression model 
adjusted for a propensity score including more covariates. Propensity score is “the 
probability of receiving one of the treatments being compared, given the measured 
covariates” [160]. The use of propensity score is recommended for studies with a 
large number of confounders and a low number of events [160]. We used propensity 
score in paper I to investigate if inclusion of additional covariates would change the 
estimated effect of CAS. All four models showed that there was no statistically 
significant difference between CAS and CON, and the estimated treatment effect of 
CAS was similar for the three Cox regression models. However, there may be 
unmeasured covariates in all models that could affect the results. 
Schoenfeld analysis 
When the proportional hazard assumption (PH) is fulfilled, the relative risk of 
revision between two groups is constant over time [128]. The TKA cohort in paper II 
did not fulfill PH, and this was also an issue for some revision causes for TKA 
(infection, polyethylene wear/breakage and unexplained pain) and UKA 
(polyethylene wear/breakage). For survival of TKA, the Kaplan-Meier survival was 
TKA/UKA in period 2 relative 










highest for period 1 at early follow-up, but the survival curves for period 1 and 2 
were crossing at approximately 1 year. We investigated this further by Schoenfeld 
residuals, also known as partial residual plots [161]. These plots show the relative 
risk of revision for period 2 relative to period 1, as a function of time. Inspecting the 
Schoenfeld residuals makes it easier to understand how the proportion of early and 
late revisions changed during the two time periods for a certain cause of revision.  
To address the non-PH assumption, the Cox regression model was stratified to 
follow-up intervals, where PH was fulfilled. The cut-points for these intervals were 
set individually for each revision cause, based on visual inspection of the Schoenfeld 
residuals and confirmed by statistical tests [129].  
Sample size and statistical power  
During the planning phase of paper III, power analyses were performed to calculate 
sample size for the two parts of the trial; RSA and PROs. We used 80% power and 
significance level 0.05 in all the following sample size calculations. For RSA, 0.1 
mm was considered a clinically relevant difference between the groups. With a 
standard deviation of 0.1, 17 patients in each group was required. Due to the risk of 
drop-outs, 26 CAS and 28 CON were included. The MIC for KOOS was used to 
calculate the sample size for comparisons of PROs. As suggested from the developers 
of KOOS, a difference of 10 units was considered clinically relevant [113], and a 
standard deviation (SD) of 20 was used to calculate sample size. We needed 64 
patients in each group, and 192 patients (97 CAS, 95 CON) were initially enrolled in 
the study. At 5 years, 21 patients in each group had valid RSA measures and 160 
patients (82 CAS, 78 CON) participated at 5 years follow-up. All PRO subscales had 
at least 70 patients in each group. With this number of patients, we consider the 
power of the analyses as adequate. 
As discussed in section 1.2, MIC should not be used to find between-group 
differences. In paper III, we used responder analyses as a secondary outcome. The 
responder criteria are based on changes in scores in the individual patient; an increase 
in absolute score of ≥20 points in pain or function, or ≥10 points in two out of three 
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of pain, function and global assessment of the disease defined a responder. The 
number of patients in paper III was based on differences in KOOS and the number 
was not necessarily high enough to prove a difference in the proportion of responders.  
6. Discussion on the results  
2.1. Survival of computer navigated implants 
The main purpose of paper I was to compare CAS and CON with respect to implant 
survival and relative risk of revision. We found an almost identical implant survival 
at 8 years with 94.8% for CAS and 94.9% for CON. The AOANJRR did a study 
comparing CAS and CON in primary TKAs performed in Australia from 2003 to 
2012. They found that the 9 years survival was 95.4% for CAS and 94.8% for CON, 
and this was not a significant difference. However, a subgroup of patients <65 years 
of age had a higher cumulative revision rate for CON compared to CAS, and the 
hazard ratio was 1.13 (CI: 1.03-1.25, p=0.01) [162]. In paper I, the relative risk of 
revision for patients of all ages and for patients <65 years was 0.8 (CI: 0.6-1.1, p=0.1) 
for CAS compared to CON, and the differences were not statistically significant. 
Knee prostheses have a low rate of revision, thus a large sample size and long follow-
up is required to identify if one implant or method is beneficial compared to another. 
A power calculation (not published) showed that 8158 patients is needed in each 
group to detect an increase in survival from 94% to 95% (power 80%, significance 
level 0.05) [163]. Our study did not have enough CAS patients to detect a difference 
between the groups according to this calculation. Thus, there is a risk of type II error, 
which means failing to reject a false null hypothesis. Australia has a larger population 
than Norway and a higher life time risk of knee arthroplasty [6]. In addition, a higher 
proportion of knee arthroplasties in Australia are performed with CAS [9]. 
Consequently, the Norwegian cohort needs a longer period of inclusion and a longer 
follow-up to achieve a similar statistical power. The 13% increased risk of revision 
for the Australian below 65 cohort is not necessarily clinically significant, and can be 
caused by a number of factors others than the use of CAS and CON; surgeon factors, 
patient factors and selection bias to mention some. Low power may also explain why 
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RCTs with a long follow-up do not find difference in survival between CAS and 



















Paper I – Dyrhovden et al. 2016 (NAR) 




CON 20019 6481 94.9 92.4 1 1 
de Steiger et al. 2015 (AOANJRR) 





CON 270545 87984 94.8 92.2 1 1 
* 8 years survival for NAR, 9 years survival for AOANJRR 
** HRs are inverted for easier comparison (presented as CON relative to CAS 
in the article) 
Table 5. Comparison of the number of patients and results of paper I and de Steiger 
et al. 2015 [162]. 
 
We included five prosthesis brands in the paper I; AGC (Biomet, Warsaw, IN, USA), 
Duracon (Stryker, Kalamazoo, MI, USA), e.motion (B. Braun, Melsungen, 
Germany), LCS complete (DePuy, Warsaw, IN, USA) and Profix (Smith & Nephew, 
Memphis, TN, USA). We compared CAS and CON in subgroups of each prosthesis 
brand, but found no significant difference in relative risk of revision in the adjusted 
Cox regression model. This result differs from the short-term follow-up from 2011 by 
Gøthesen et al. [123]. In the short-term follow-up, the mobile bearing LCS complete 
had a significantly higher risk of revision in CAS compared to CON (RR=2.1, CI: 
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1.3-3.4), whereas the other prosthesis brands had no difference in risk of revision for 
CAS versus CON [123]. There is no clear reason why the LCS complete had a higher 
risk of revision at short-term, but the authors suggested that the inferior survival may 
result from technical difficulties with navigation of the implant. In addition, LCS 
complete had a high risk of revision compared to Profix implants in a study of non-
navigated TKAs from the NAR, primarily due to an increased risk of loosening of the 
tibial component (RR=7.7, CI: 4.1-14.4) [71]. However, the use of CAS did not affect 
the risk of revision for LCS complete in paper I. This could result from a learning 
curve at the hospitals using CAS for LCS complete or due to updated versions of the 
navigation system used with LCS complete. Unfortunately, the software version of 
the navigation system is not reported to the NAR, and we were therefore not able to 
control for this. 
The arthroplasty register in New Zealand compared CAS and CON using the 
Triathlon TKA system at 5 years follow-up [56]. According to their findings, CAS 
and CON had similar risk of revision for all implants and a non-significant tendency 
of higher risk of revision for CAS in patients <65 years. This indicates that survival 
of CAS may be implant-specific and illustrates that introduction of new technology 
could increase the risk of revision, despite promising results in small-scale studies.  
Another important question is whether the rate of improvement is clinically and 
economically relevant. Gøthesen et al. used a Markov model to calculate the 
percentage improvement in implant survival that is needed to be cost-effective [166]. 
The cost-benefit calculation was based on the Norwegian health care sector’s 
threshold value for acceptable added cost per quality-adjusted life year gained [167]. 
The result depended on the hospital’s annual TKA volume and the average age of the 
patients. In a cohort of patients aged 60 years and an annual hospital volume of 25 
TKAs, an improvement in 10 years survival from 89.8% to 90.6% is cost-effective. If 
the age of the patients increase to 75 years and the hospital volume is 250 TKAs 
annually, cost-effectiveness is achieved with an improvement in 10 years survival 
from 95.4% to 95.7%. A study by Slover et al. suggested that the annual revision rate 
should be reduced with 2% in a center with 250 CAS procedures annually and 13% in 
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a center with 25 annual procedures [168]. Both studies indicate that CAS is cost-
effective in high-volume centers, but is less likely to be cost-effective in centers with 
a low annual CAS volume. Based on the results from paper I, introducing CAS in a 
large scale is so far not cost-effective in Norway.  
2.2. Learning curve 
In the NAR paper on short-term follow-up of CAS and CON, 2 years survival was 
96% for CAS and 98% for CON [123]. One possible explanation for the difference is 
that there was a learning curve in each hospital during introduction of CAS. Smith et 
al. and Jenny et al. studied the learning curve of CAS, comparing TKA patients 
operated by experienced CAS surgeons compared to surgeons unexperienced with 
CAS [126, 169]. The experienced and unexperienced surgeons had similar results 
regarding post-operative alignment, functional outcomes (Oxford knee score, Knee 
Society score and range of motion) and complications. In both studies, the operating 
time was longer for unexperienced surgeons, but this difference was not found after 
20-30 operations for all included centers.  
To explore the learning curve in paper I, we divided the CAS patients in two groups; 
one group including the 30 first CAS TKAs at each hospital (unexperienced group) 
and the rest of the CAS TKAs in the second group (experienced group). Comparing 
CAS patients in the unexperienced group to all CON patients, we found no difference 
in relative risk of revision (RR=1.1, CI: 0.7-1.5). In the unexperienced group, median 
operating time was 31 minutes longer than for the CON group (p<0.001). In contrast 
to the studies by Smith et al. and Jenny et al., the operating time in the experienced 
CAS group was still 17 minutes longer than for the CON group (p<0.001). One 
explanation could be that many hospitals have more than one surgeon performing 
CAS, and the learning curve for one hospital would be more than 30 procedures if the 
operations are dispersed on a number of surgeons. In a previous Norwegian study, 
one experienced surgeon performed all operations in the CAS and CON group, using 
11 minutes longer for CON in average (p<0.001) [170]. This study exemplifies that 
an experienced surgeon can use CAS without adding time compared to CON. 
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2.3. Time trends in survival free from revision for TKA and UKA 
The 10 years survival rate for TKA improved from 91% in period 1 to 94% in period 
2. A similar improvement is reported from the Swedish Knee Arthroplasty Register 
(SKAR) [11], which showed an improved 10 years survival from 92% for TKAs 
performed during 1987 to 1996 to 96% during 2007-2016. The survival for TKA in 
NAR is comparable to what other joint registries found from the same time period, 
shown in table 6. UKA had a non-significant improved 10 years survival rate from 
80% in period 1 to 81% in period 2. This survival rate is dramatically lower than for 
TKA, but also lower than the UKA survival rates that are reported from some other 
large joint registries (table 6). The differences between countries could be explained 
by various reasons, like differences in implants, fixation, selection of patients, 
surgeon/hospital volumes, thresholds for revision, and completeness of reporting of 
revisions. Improvement of implant survival is multifactorial, and correlations found 
in registry studies must be confirmed by RCTs.  
Joint registry  TKA 10 years  
survival rate (%) 
UKA 10 years  
survival rate (%) 
Year of 
operation 
NAR (Norway, paper II) 94 81 2005-2015 
SKAR (Sweden) [11] 96 86 2007-2016 
AOANJRR (Australia) [9] 95 85 2003-2017 
NZJR (New Zealand) [66] 96 90 2000-2017 
NJR England & Wales [10] 96 89 2003-2017 
Table 6. Overview of 10 years survival rates of TKA and UKA from paper II 
compared to other large joint registries.  
 
Previous registry studies from NAR have shown a correlation between a high hospital 
volume and a lower risk of revision for TKA and UKA [82, 83]. Since 2000, there 
was an increase in hospitals with a high UKA volume (more than 21 per year), but 
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also an increase in the number of hospitals with an annual UKA volume less than 10. 
The type of implants changed extensively from period 1 to period 2 for TKA, 
whereas the Oxford® Phase 3 was the dominant UKA implant in both periods, 
indicating that improvement in design was less extensive for UKA as for TKA. Since 
its introduction in 2011, the use of Oxford Partial Knee has increased to >90% of 
UKAs in Norway in 2016-2018 [3]. A high use of one implant could be an advantage 
in a country with a low number of UKAs annually, but it is also vulnerable since 
long-term results of this specific implant is unclear, and continuous surveillance of 
UKA survival is necessary.  
2.4. Causes of revision  
Revision causes for computer navigated TKAs (paper I) 
In paper II, deep infection and malalignment were the most common revision causes. 
The rate of deep infection was similar for CAS and CON, but the CAS group had a 
lower risk of revision due to malalignment. This indicates that CAS leads to fewer 
patients with severe malalignment and need for a subsequent revision. This finding 
fits with the results from previous studies, in which CAS patients had fewer outliers 
on postoperative radiographs [27, 44, 50, 53, 170-173]. In the survivorship study 
from AOANJRR, the CAS group had a significantly lower risk of revision due to 
loosening in patients <65 years. Loosening was the most common revision cause for 
both CAS and CON in this age group [162]. Differences between the two registry 
studies could be explained by differences in patient demographics or the use of 
implants. The Australian study included adjustments for age and sex only, whereas 
factors like implant, fixation method or diagnosis were not taken into account. If 
important demographic variables differed among the study groups, it could skew the 
results, as shown in previous studies and reports from arthroplasty registers [3, 9, 71].  
Time trends in revision causes for TKA and UKA (paper II) 
In paper II, patients are included in the registry over a long period of time, and 
changes over time in registration procedures may affect the results. This type of bias 
is difficult to detect, because the bias and the change in revision cause are trends that 
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change over time. One example is the inclusion of the revision cause “progression of 
osteoarthritis”, that was introduced in the NAR registration form in 2011. Before this 
change, the surgeon would have to tick the box “other” and then write “progression 
of osteoarthritis” in a text-field in hand writing. Possibly, many surgeons classified 
these patients with “pain” or “other” with no further specification. Consequently, 
there was a dramatic increase of revisions due to progression of osteoarthritis from 1 
TKA and 4 UKA in period 1 to 21 TKA and 83 UKA in period 2.  
Unexplained pain was a common revision cause for TKA and UKA in both periods. 
This high number could be caused by misclassification, but it is still worrying that 
many patients are revised without a clear diagnosis. From our data, it is impossible to 
distinguish between a real change in revisions for unexplained pain and a change in 
registration procedures. In addition to this example, there may also be other less 
obvious changes in the classification of revisions that influence the results. If surgeon 
awareness for a specific revision cause is changed, i.e. infections, the registered 
number of revisions for infection will increase regardless of the real number of 
infections.  
From period 1 to period 2, there was a decline in revisions caused by polyethylene 
wear/breakage. In 2013-2015, highly crosslinked polyethylene was only used in 8% 
of TKAs [174], indicating that locking mechanisms, sterilizing and polishing has also 
played a role in improving the quality of polyethylene components [175-177]. 
Improvements in implant design, like improved patella tracking, may have 
contributed to the reduction of revisions resulting from aseptic loosening of the 
femoral component and patella dislocation. It is also shown that pressurizing and bi-
surface cementing technique reduces loosening of the femoral component [178]. The 
same change was not found for the tibial component, and tibial loosening was the 
third most common revision cause in period 2.  
The most commonly used implant in period 2 was LCS complete, which has 
previously shown an increased risk of tibial aseptic loosening (RR=7.7, CI: 4.1-14.4) 
in a Norwegian registry study [71]. The high use of this implant probably contributed 
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to the lack of improvement in tibial loosening in period 2. A Norwegian retrieval 
study of revised LCS complete tibial components found that 12 of 22 components 
loosened at the implant-cement interface, and only 3 at the bone-cement interface 
[179]. A low surface roughness, non-keeled stem and a thin cement layer were 
suggested as possible reasons for mechanical loosening. Although this study only 
included one implant design, the results illustrate that improvement in design and 
cementing technique for the tibial component is needed.  
Arthrofibrosis was not a common revision cause. This diagnosis is not well defined 
and reoperations for this reason often includes soft tissue procedures without 
component removal or exchange, which are not included in the NAR. For this reason, 
a consensus statement from 2016 suggested that joint registries are not suitable to 
identify patients with post-surgical joint fibrosis [180]. Thus, the true number of 
patients with arthrofibrosis in paper II is unknown.  
The risk of early postoperative revisions for infection was increased in period 2, with 
a fivefold increase the first 1.5 months. A similar increase is also observed in 
Scandinavian studies of hip arthroplasties [181, 182]. One explanation could be a new 
approach to prosthetic infections, with higher awareness and earlier removal of the 
components (rather than protracted antibiotic treatment) [183]. Higher awareness to 
infections could also lead to an improved reporting rate of low-grade infections. 
These patients may have been classified as “aseptic loosening” or “pain” in period 1. 
Since the registration form is completed immediately after surgery, the diagnosis is 
not confirmed by microbiological samples. Over-reporting of uncertain infections, 
such as prolonged wound drainage, could have contributed to a high number of 
reported infections in period 2. Early revision of infection can be one explanation to 
the lower risk of late revision (>1 year) for infection in period 2, but this cannot be 
concluded from a registry study.  
Instability and malalignment are still important causes of failure for TKA, which was 
also found by Thiele et al. [74]. This illustrates the importance of optimizing 
alignment and soft tissue balancing in knee arthroplasty, in which CAS could be an 
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important tool. In paper I, fewer revisions for malalignment was observed in the CAS 
group. A more extensive use of CAS may contribute to address the problem of 
malalignment and instability, but this should be explored in future studies with a 
higher number of patients than in paper I. 
In paper II, UKA was not divided into medial and lateral UKA. Lateral UKA is far 
less common than medial UKA and the procedure is considered different regarding 
surgical technique and outcome [184]. Previous studies of lateral UKA failure include 
a small number of patients and the causes of revision are not shown to be different 
from medial UKA revisions [185]. Survival of lateral UKA was similar to medial 
UKA in a review by van der List et al. [186]. Registration of medial and lateral UKA 
started in 1999 in NAR, and the variable has many missing values. We did no 
separate analyses of medial and lateral UKA in paper II due to this uncertainty. There 
are few lateral UKA in Norway and the results from paper II are most relevant for 
medial UKA.  
 Medial Lateral Missing data 
Period 1 929 17 1351 
Period 2 4369 63 919 
Table 7. The number of medial UKA, lateral UKA and missing data (UKAs not 
classified as medial or lateral) in period 1 (1994-2004) and period 2 (2005-2015).  
 
2.5. Radiological outcomes 
RSA 
5 years postoperative, there was no statistically significant difference in rotation or 
migration of the tibial component for CAS and CON; the same result as Petursson et 
al. found at 2 years follow-up [131]. This also correlates with a systematic review by 
Pijls et al., where cemented TKAs had little migration from 6 months to 5 years [92]. 
Teeter et al. found that varus alignment of the tibial component after TKA was 
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associated with increased migration and lateral liftoff at 10 years follow-up [90]. In 
our study, only 5 patients had postoperative tibial varus alignment, and the study was 
underpowered to correlate alignment to migration. We found no other studies 
comparing migration for CAS and CON after TKA. There was a tendency of more 
migration (MTPM) in the CAS group. Possibly the difference would have proven 
significant if we had more patients (type II error). Due to a low number of patients in 
the RSA study however; a couple of outliers can significantly skew the results, as 
discussed earlier. 
Radiolucent lines 
A comparison of radiolucent lines around the components was one of the secondary 
outcomes in paper III. Results from 3 months and 5 years postoperative radiographs 
showed that only 9 patients had radiolucent lines of >4mm at 5 years, and there was 
no significant difference between CAS and CON. Napier et al. found radiolucent 
lines of >1mm in 12 out of 240 knees 10 years after TKA with LCS complete, 
supporting that radiolucent lines are not very common after TKA, even at long-term 
follow-up [187]. To our knowledge, no other studies have compared radiolucent lines 
for CAS and CON. The correlation between radiolucent lines and loosening of the 
implant is uncertain and has not been confirmed in contemporary studies [188]. Only 
7 of the patients included in paper III were revised within 5 years (3 infection <2 
months, 1 instability, 1 periprosthetic fracture, 1 arthrofibrosis, 1 unexplained pain), 
and this number is too low to associate revisions to radiolucent lines. 
2.6. Patient reported outcomes (PROs) 
In paper III, CAS had more high responders for pain score, and the number needed to 
treat (NNT) was 7. There was no significant difference in the number of patients 
classified as high responders in function or the proportion of high, moderate or non-
responders according to the OMERACT-OARSI criteria. At 2 years follow-up from 
the same trial, the CAS group had more high responders for both pain and function 
[130]. Compared to the CON group, CAS also had more patients classified as high 
responders and fewer patients classified as moderate responders at 2 years [130]. At 2 
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years, 3 of 11 PRO subscales were significantly in favor of CAS, whereas none of the 
subscales differed statistically or clinically significant between CAS and CON at 5 
years (paper III). To our knowledge, no other clinical trials have used responder 
analyses in comparing CAS and CON over time. Kim et al. presented a randomized 
trial with 15 years follow-up of 282 patients younger than 65 years old, operated by 
the same surgeon with bilateral TKA; one knee operated with CAS and one knee 
operated with CON [55]. They found no difference in alignment, Kaplan-Meier 
survivorship, KSS, WOMAC score, UCLA activity score or patient satisfaction at 
final follow-up. The study had a high proportion of female patients (74%) and a 
lower age (59 (SD 5) years) compared to the patients in paper III (60% women, age 
69 (SD 7) years, so the results are not directly comparable. Still, it shows similar 
long-term results for CAS and CON, which is comparable to the 5 years follow-up in 
paper III. Comparing the results at 2 and 5 years from the same patients, it seems like 
the differences in PROMs are equalized within 5 years. This may indicate that the 
long-term clinical benefit of CAS is small. Similar results at 5 years could also be a 
result of response shift, which means that the patients adapt to their new situation 
over time [98].  
Both CAS and CON had a high improvement in PRO scores from preoperative to 5 
years. In 10 of the 12 included PRO dimensions, CAS had a higher number of 
patients achieving the highest possible score (ceiling effect). A similar pattern was 
found in the 2-years follow up of the same patients; all PRO dimensions had higher 
ceiling effect in the CAS group, and the difference was statistically significant in 4 
PRO dimensions. The lowest ceiling effect was found for KSS knee score and KOOS 
SportRec [130]. A study by Aunan et al. comparing patella resurfaced and non-
resurfaced TKA found a high ceiling effect for KSS function score, VAS-satisfaction 
and KOOS (19-40%). KSS knee score and Oxford knee score had 16% ceiling effect, 
and KOOS SportRec had the lowest ceiling effect (6%) [189]. 
When a high number of patients reach a ceiling effect, it indicates that the scoring 
system is not capable of detecting the size of the improvement from the treatment. A 
high ceiling effect increases the risk of type II error; to overlook a true difference 
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between the groups. Ceiling effect is an important limitation, and a maximum ceiling 
effect of 15% is a quality criterion for health status questionnaires [99]. In paper III, 
the ceiling effect was above 15% in 10 out of 12 PROs for CAS and 6 out of 12 
categories for CON. KOOS SportRec had the lowest ceiling effect with 9% for CAS 
and 4% for CON. The average improvement from preoperative to 5 years for KOOS 
SportRec was 7.6 points (CI: -1.9-17, p=0.1) higher in the CAS group compared to 
CON, which was the category with the largest difference in improvement among the 
treatment groups. We do not know how high the patients would score on a scale with 
no ceiling effect or whether there would be a difference in scores between CAS and 
CON. Higher ceiling effect for CAS patients could indicate that CAS would have the 
highest scores in a different scale, but this cannot be confirmed by the data in paper 
III.  
Due to the increasing demand of TKAs in the future and patient’s high expectations, 
there is a need for further improvement in the outcome of TKA. Although the PROs 
in paper III did not show a difference between CAS and CON, the available scoring 
systems are not sensitive enough to separate “good” from “very good” results. The 
Forgotten Joint Score is shown to be more responsive to change compared to 
WOMAC and EQ-5D, and it has a low ceiling effect compared to WOMAC, EQ-5D, 
KSS and Oxford Knee Score (Still, the ceiling effect is 16-33% at 1-4 years follow-
up after TKA, which is higher than recommended) [190, 191]. If CAS is a method 
that can improve the result of an average patient from good to very good, the method 
could be beneficial regardless of improvement in survival rates. To answer this 
question, future studies should use scoring systems for knee-specific health status 





Paper I  
 In the Norwegian cohort, CAS and CON did not differ significantly in 8 years 
overall survivorship. 
 Patients operated with CAS had a lower risk of revision due to malalignment. 
Paper II  
 There was an improvement in overall survivorship for TKA in the last time 
period, but similar improvement was not found for UKA, and the survivorship 
for UKA remains remarkably lower than for TKA. 
 TKA had an increasing risk of early revisions due to infection and a decrease 
in risk of revision due to aseptic loosening of the femoral component, patella 
dislocation, polyethylene wear/breakage and unexplained pain. UKA had more 
revisions resulting from progression of osteoarthritis in period 2, but a 
decrease in revisions resulting from aseptic loosening, polyethylene 
wear/breakage and periprosthetic fractures. 
 For TKAs and UKAs, age younger than 65 years was associated with a higher 
risk of revision. For TKAs, a higher risk of revision was found for male sex, 
but sex did not affect the risk of revision for UKAs. 
Paper III 
 There was no statistically significant difference in implant migration or the 
occurrence of radiolucent lines between CAS and CON at 5 years follow-up. 
 The CAS group had a higher number of patients with a high pain reduction 
compared to the CON group, but there was no difference in the number of 
responders based on mean pain, function and quality of life.  
 There were no differences in the amount of improvement of patient-reported 
pain, function and quality of life from preoperative to 5 years follow-up 




Long term survivorship with at least 15 years follow-up of CAS versus CON should 
be evaluated, including patient characteristics that are associated with a higher or 
lower risk of revisions in the CAS group. This is especially important since CAS is 
claimed to improve survivorship in young patients, with a long life expectancy. To 
find the best selection of patients for CAS, it is also important to identify subgroups 
of patients that have the highest benefits of CAS (i.e. age groups, comorbidities, 
preoperative PROs).  
Despite the improvement of TKA survival the last decade, it is concerning that 
survival of UKA is unchanged. Future studies should focus on factors that can 
improve UKA survival, i.e. patient selection and implant design. New technologies 
should be developed to simplify this technically demanding procedure, and CAS and 
robotic technology may be a tool worth studying for UKA as well. 
A large, population-based randomized trial that compares survivorship and PROs in 
CAS compared to CON is needed. A registry-based randomized trial is a suitable 
design, because a large patient sample could be included at low costs compared to 
traditional RCTs. To perform this type of study, a knee arthroplasty register that 
collects data on revisions and PROs pre- and postoperatively is needed.  
It is still uncertain whether malalignment leads to poor implant survival. To address 
this issue, a study that correlates alignment to migration by RSA or long term 
survival should be performed. Malalignment and instability are still common revision 
causes. Further development of implants and technologies is important to reduce the 
number of these revisions. However, this should be introduced in a small scale, under 
control of RCTs and registry studies to control the effects in short and long term.  
For most patients the clinical outcome after TKA is very good. There is a need of 
knee-specific scoring systems with a low ceiling effect in order to separate good from 
very good results. Such a scoring system would be useful in studies of CAS and also 
generally for patient groups with high demands of knee function.  
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Nasjonalt Register for Leddproteser 
Ortopedisk klinikk, Helse Bergen HF 
Haukeland universitetssjukehus, Postboks 1400 
Møllendalsbakken 11, 5021 BERGEN 
Tlf  55973742/55973743 
KNEPROTESER og andre leddproteser 
Innsetting, skifting eller fjerning av protese eller protesedeler, samt bløtdelsrevisjoner for infisert protese og protesenære frakturer. 
12.01.2018 
F.nr. (11 sifre)..................................................................... 
Navn:.................................................................................. 
(Skriv tydelig ev. pasientklistrelapp – spesifiser sykehus.) 
Sykehus:............................................................................ 
LOKALISASJON, AKTUELL OPERASJON 
1 Kne  6 Håndledd 
2 Ankel 7 Fingre (angi ledd) …………………. 
3 Tær (angi ledd) …………….. 8 Annet ……………………………….. 
4 Skulder   9 Rygg (angi nivå)………..………… 
5 Albue 
AKTUELLE SIDE (ett kryss) (Bilateral opr. = 2 skjema) 
1 Høyre  2 Venstre 
TIDLIGERE OPERASJON I AKTUELLE LEDD (ev. flere kryss) 
0 Nei 





6 Annet (f.eks menisk og leddbåndsop.).………………………………………… 
AKTUELLE OPERASJON (ett kryss) 
1  Primæroperasjon   2 Reoperasjon (protese tidligere) 
OPERASJONSDATO (dd.mm.åå) |__|__| |__|__| |__|__|   
ÅRSAK TIL AKTUELLE OPERASJON (KRYSS AV ENTEN I A ELLER B) 
A. Primæroper. pga (ev. flere kryss) B. Reoper. pga (ev. flere kryss)
1 Idiopatisk artrose 1 Løs prox.protesedel
2 Rheumatoid artritt 2 Løs distal protesedel
3 Fraktursequele……………  3 Løs patellaprotese
4 Mb. Bechterew       4 Luksasjon av patella
5 Sequele ligamentskade      5 Luksasjon (ikke patella)
6 Sequele meniskskade      6 Instabilitet
7 Akutt fraktur  7 Aksefeil
8 Infeksjonssequele       8 Dyp infeksjon
9 Spondylose      9 Fraktur av bein (nær protesen)
10 Sequele prolaps kirurgi 10 Smerter
11 Degenerativ skivesykdom 11 Slitt eller defekt plastforing
12 Rotarcuff artropati Hvilken………….…………… 
13 Annet …………………………… 12 Progresjon av artrose 
13 Annet (f.eks tidl fjernet protese) 
…………………………..………………. 
REOPERASJONSTYPE (ev. flere kryss) 
1 Bytte el. innsetting av distal komponent 9 Fjernet protesedeler (inkl. 
2 Bytte el. innsetting av proximal protesedel       sementspacer) 
3 Bytte el. innsetting av hele protesen         Angi hvilke deler …………….. 
4 Innsetting av patellakomp. …………………………..……. 
5 Bytte av patellaprotese 10 Bløtdelsdebridement for 
6 Bytte av plastforing        infisert protese 
7 Artrodese 
8 Amputasjon 
11 Osteosyntese av 
protesenær fraktur. Angi hvilket 
ben ……………………………... 
12 Annet……………..……….. 
BENTRANSPLANTASJON  / BENERSTATNING (ev. flere kryss) 
Proximalt    0 Nei      1 Ja      2 Benpakking     3 Kjegler (cones) 
Distalt     0 Nei     1 Ja    2 Benpakking    3 Kjegler (cones) 
ANTIBIOTIKAPROFYLAKSE          0 Nei 1 Ja  
    Navn    Dosering   Varighet i timer  
Medikament 1........………………….…………………….…     .….……timer 
Medikament 2........………………….…………………….…     .….……timer 
TROMBOSEPROFYLAKSE  
0 Nei  1 Ja:   Første dose  1 Preoperativt   2 Postoperativt 
Medikament 1…………………...Dosering opr.dag…………………………………. 
   Dosering videre…..…….Varighet.….……døgn 
Medikament 2………………….. Dosering…………..…….Varighet.….……døgn 
FAST TROMBOSEPROFYLAKSE 
0 Nei 1 Ja, type: ………………………………………………………………….. 
FIBRINOLYSEHEMMER 
0 Nei 1 Ja, medikament: ………………………………….. Dosering…………. 
DREN    0 Nei   1 Ja.   Antatt varighet …………………døgn  
OPERASJONSTID (hud til hud) ……………………………minutter 
BLODTOMHET    0 Nei   1 Ja     BLODTOMHETSTID…………….… minutter 
BLODTOMHET UNDER SEMENTERING     0 Nei   1 Ja  
PEROPERATIV KOMPLIKASJON 
0  Nei    1  Ja,hvilke(n): .........................................................................................
MINI INVASIV KIRURGI (MIS)  0 Nei 1 Ja 
COMPUTERNAVIGERING (CAOS)  0 Nei 1 Ja Type:…………………..
PASIENTTILPASSEDE INSTRUMENTER 0 Nei 1 Ja Type:…………………..
ASA KLASSE (se baksiden for definisjon)  
1 Frisk  
2 Asymptomatisk tilstand som gir økt risiko 
3 Symptomatisk sykdom 
4 Livstruende sykdom 
5 Moribund
PROTESE KNE (Bruk klistrelapper på baksiden, eller spesifiser nøyaktig) 
PROTESETYPE 
 1 Totalprot. m/patella  .  4 Patellofemoralledd prot. 
 2 Totalprot. u/patella   5 Bi-compartmental  6 Hengslet protese  
 3 Unicondylær prot     Medial     Lateral    7 Annet …………………….. 
FEMURKOMPONENT 
Navn/Type/Str / evt. Katalognr…………….………………………………………... 
ev. katalognummer …………………………………………………………………... 
Sentral stamme   0 Nei 1 Ja, ev. lengde ………………….mm 
Sementert stamme   0 Nei 1 Ja 
Metallforing (Wedge) 0 Nei 1 Ja 
Stabilisering  0 Nei 1 Ja, bakre 2 Ja, annen 
 1 Sement med antibiotika – Navn ………………………………………………. 
 2 Sement uten antibiotika – Navn ………………………………………………. 
 3 Usementert 
TIBIAKOMPONENT (metallplatå) 
Navn/Type/Str / ev. katalognummer …………………………….…………………. 
Forlenget sentral stamme  0 Nei 1 Ja, ev. lengde ………mm 
Sementert stamme         0 Nei 1 Ja 
Metallforing (Wedge) 0 Nei 1 Ja 
1 Sement med antibiotika – Navn …………………………………………….…. 
2 Sement uten antibiotika – Navn ………………………………………….……. 
3 Usementert 
TIBIAKOMPONENT (plastkomponent) 
Navn/Type/Str / ev. katalognummer….………………………………….…………. 
Tykkelse …………………….. mm 
Stabilisering 0 Nei 1 Ja, bakre 2 Ja, annen 
PATELLAKOMPONENT 
Navn/Type/Str / ev. katalognummer…..……………………………………..……. 
Metallrygg   0 Nei 1 Ja 
1 Sement med antibiotika – Navn ………………………………………….……. 
2 Sement uten antibiotika – Navn …………………………………………….…. 
3 Usementert 
KORSBÅND 
Intakt fremre korsbånd før operasjon  0 Nei  1 Ja 
Intakt fremre korsbånd etter operasjon      0 Nei 1 Ja 
Intakt bakre korsbånd før operasjon  0 Nei  1 Ja 
Intakt bakre korsbånd etter operasjon 0 Nei  1 Ja
PROTESE ANDRE LEDD (Bruk klistrelapper på baksiden, eller spesifiser nøyaktig) 
PROTESETYPE 
1 Totalprotese   2 Hemiprotese   3 Enkomponentprotese   4 Annet ….. 
PROKSIMAL KOMPONENT 
Navn/Type/Str / ev. katalognummer…..………………………………………..…. 
1 Sement med antibiotika – Navn …………………………………………….…. 
2 Sement uten antibiotika – Navn ………………………………………...……... 
3 Usementert 
DISTAL KOMPONENT 
Navn/Type/Str / ev. katalognummer……………………………………………...... 
1 Sement med antibiotika – Navn …………………………………………….…. 
2 Sement uten antibiotika – Navn ……………………………………………….. 
3 Usementert 
INTERMEDIÆR KOMPONENT (f.eks. caput humeri) 
Navn/Type/Str/Diameter / ev. katalognummer..………………………………..…. 
Lege ................................................................................................... 
Legen som har fylt ut skjemaet (navnet registreres ikke i databasen).
RETTLEDNING KNEPROTESER og andre leddproteser 
 
Registreringen gjelder innsetting, skifting eller fjerning av protese i kne, skuldre og andre ledd med unntak av hofter som har eget skjema. Ett skjema fylles 
ut for hver operasjon. Pasientens fødselsnummer (11 sifre) og sykehus må være påført. Aktuelle ruter markeres med kryss. 
På eget Samtykkeskjema skal pasienten gi samtykke til rapportering til Leddregisteret.  
 
Kommentarer til de enkelte punktene  
AKTUELLE OPERASJON  
Primæroperasjon: Dette er første totalproteseoperasjon. 
Kryss av enten i A eller i B. Kryss av for alle årsakene til operasjonen. Bløtdelsrevisjon for infeksjon skal registreres selv om protesedeler ikke skiftes. 
REOPERASJONSTYPE  
Fjerning av protesedeler må spesifiseres og føres opp, også fjerning ved infeksjon. 
BENTRANSPLANTASJON  
Påsmøring av benvev rundt protesen regnes ikke som bentransplantat. 
ANTIBIOTIKAPROFYLAKSE 
Medikament, dose og varighet av profylaksen skal angis f.eks. slik: Medikament: Keflin, Dosering: 2g x 4, med varighet 4,5 timer. 
TROMBOSEPROFYLAKSE 
Medikament, dose og antatt varighet av profylaksen skal angis separat for operasjonsdagen og senere. Det skal også oppgis om pasienten står fast 
på tromboseprofylakse (AlbylE, Marevan, Plavix ol). 
FIBRINOLYSEHEMMER  
Her føres det på om en benytter blødningsreduserende legemidler i forbindelse med operasjonen (f.eks. Cyklokapron). 
PEROPERATIV KOMPLIKASJON  
Dersom det foreligger komplikasjon i form av stor blødning, må mengden angis. 
Dersom pasienten dør under eller like etter operasjonen, ønsker vi likevel melding om operasjonen. 
       ASA-KLASSE  (ASA=American Society of Anesthesiologists) 
       ASA-klasse 1: Friske pasienter som røyker mindre enn 5 sigaretter daglig. 
       ASA-klasse 2: Pasienter med en asymptomatisk tilstand som behandles medikamentelt (f.eks. hypertensjon) 
                  eller med kost (f.eks. diabetes mellitus type 2) og ellers friske pasienter som røyker 5 sigaretter eller mer daglig. 
  ASA-klasse 3: Pasienter med en tilstand som kan gi symptomer, men som holdes under kontroll medikamentelt 
                          (f.eks. moderat angina pectoris og mild astma). 
  ASA-klasse 4: Pasienter med en tilstand som ikke er under kontroll (f.eks. hjertesvikt og astma). 
  ASA-klasse 5: Moribund/døende pasient  
PROTESETYPE  
Dersom det er gjort revisjon av totalprotese uten patellakomponent og REOPERASJONSTYPE er innsetting av patellakomponent, skal det krysses 
av for pkt. 1: Totalprotese med patellakomponent (dvs. protesen har nå blitt en totalprotese med patellakomponent). Ved revisjon av unicondylær 
protese til totalprotese brukes enten pkt. 1 eller 2. 
PROTESEKOMPONENTER  
Her anføres kommersielle navn, materiale, størrelse og design. Alternativt kan en føre opp protesenavn og katalognummer eller benytte klistrelapp 
som følger med de fleste protesene. Denne kan limes på baksiden av skjemaet (vennligst ikke plasser klistrelapper på markeringskryss, som 
brukes ved scanning av skjema).  
Navnet på sementen som evt. brukes må anføres, f.eks. Palacos R+G. (Bruk helst klistrelapp) 
Under femurkomponent skal evt. påsatt femurstamme anføres med lengde. 
Med metallforing under femur- og tibiakomponent menes bruk av en eller flere separate metallkiler (wedges) som erstatning for manglende benstøtte. 
Stabilisering er bruk av proteser med stabilisering som kompensasjon for sviktende båndapparat. 
Forlenget sentral stamme under tibiakomponent (metallplatå) skal bare anføres ved bruk av en lengre påsatt stamme enn standardkomponenten. 
ANDRE LEDD. PROTESETYPE  
Ved bruk av hemiprotese med bare en komponent, f.eks. resurfacing i skulder, skrives dette på DISTAL KOMPONENT.  Enkomponent-protese i 
finger/tå, skrives på PROKSIMAL KOMPONENT. 
COMPUTERNAVIGERING  (CAOS = Computer Aided Orthopaedic Surgery)  
Angi firmanavn på computersystem. 
      MINIINVASIV KIRURGI (MIS = Minimally Invasive Surgery)  
Her menes at kirurgen har brukt kort snitt og at det er brukt spesialinstrument laget for MIS. 
PASIENTTILPASSEDE INSTRUMENTER  
Her menes kutteblokker eller instrumenter som lages etter MR eller CT bilder tatt av pasienten før operasjonen. Oppgi navn på systemet. 
 
Kopi beholdes til pasientjournalen, originalen sendes Haukeland universitetssjukehus. 
 
Kontaktpersoner vedrørende registreringsskjema er  
Seksjonsoverlege Ove Furnes, tlf. 55 97 56 90.  
Overlege Randi Hole, kontaktperson (skulder), tlf. 55 97 56 79. 
Overlege Yngvar Krukhaug, kontaktperson (albue/hånd), tlf. 55 97 56 88.  
Ortopedisk klinikk, Haukeland universitetssjukehus. Besøksadresse: Møllendalsbakken 11. 
Sekretærer i Nasjonalt Register for Leddproteser, Ortopedisk klinikk, Helse Bergen:  
Randi Furnes, tlf. 55 97 37 42. 
Epost: nrl@helse-bergen.no Internett: http://nrlweb.ihelse.net/ 
Skjema revidert i januar 2018.  
Diagnosis Hierarchy for Revision Knee Replacement in the  





3 Aseptic loosening femur and tibia 
4 Aseptic loosening femur  
5 Aseptic loosening tibia 
6 Aseptic loosening patella 
7 Polyethylene wear 
8 Dislocation (not patella) 
9 Patella dislocation 
10 Instability 
11 Periprosthetic fracture 
12 Progression of osteoarthritis 
13 Arthrofibrosis 
14 Unexplained pain 
15 Other 
 
Diagnosis hierarchy for revision knee replacement, from the Australian Orthopaedic 
Association National Joint Replacement Registry, Annual report 2018 (p. 425) 
Rank Diagnosis Category 




3 Incorrect Side 
Surgical procedure 4 Incorrect Sizing 
5 Malalignment 
6 Metal Related Pathology 
Reaction to prosthesis 7 Loosening 
8 Lysis 
9 Wear Knee Insert 
Wear and implant breakage 
10 Wear Tibial Tray 
11 Wear Femoral 
12 Wear Patella 
13 Implant Breakage Femoral 
14 Implant Breakage Knee Insert 
15 Implant Breakage Tibial Tray 
16 Implant Breakage Patella 
17 Breakage Dislocation 
Stability of prosthesis/knee 
18 Patellar Dislocation 
19 Prosthesis Dislocation 
20 Instability 
21 Patellar Maltracking 
22 Fracture (Femur/tibia/Patella/Periprosthetic) Fracture of bone 
23 Progression of Disease Progression of disease on 
non-operated part of joint 24 Patellar Erosion 
25 Synovitis 
New diseases occurring in 




28 Heterotropic bone 
29 Patellofemoral Pain 
Pain 
30 Pain 
31 Other Remaining diagnoses 
 
FORESPØRSEL OM DELTAKELSE I FORSKNINGSPROSJEKT  
Profix kneprotese,  konvensjonell vs computernavigert. 
 
De skal opereres med en kneprotese. Dette er en etablert behandling med gode resultater for 
de aller fleste pasienter. Operasjonen innebærer at man setter inn et kunstig kneledd av plast 
og metall som festes med bensement. Som annen medisinsk behandling er også 
kneprotesekirurgien i stadig utvikling, og man forsøker hele tiden å finne løsninger som 
ytterligere vil bedre behandlingsresultatene. Som ledd i vår søken etter bedre løsninger vil vi 
nå sammenligne kneproteser operert med vanlig, standard metode og kneproteser operert ved 
hjelp av såkalt computernavigasjon. 
Profix-protesen er den protesen som brukes som standard i Helse Vest og på Lovisenberg 
Diakonale Sykehus, og den har gode resultater. 
Computernavigasjon har de siste 5-6 år kommet for fullt inn i protesekirurgien. I Norge er det 
få sykehus som tilbyr slik behandling. Man har foreløpig begrenset dokumentasjon på nytten 
av dette nye operasjonsverktøyet. Man bruker et infrarødt kamera som sender og mottar 
signaler under operasjonen. Signalene overføres fra kneet til en computer som lager en modell 
av kneet ditt. Ut ifra denne modellen foretas visse beregninger som hjelper kirurgen å plassere 
protesen riktig. Standardmetoden i dag er å beregne protesens plassering ved hjelp av en 
siktepinne som settes i marghulen og visse anatomiske landemerker. Vi vil undersøke hvilken 
metode som gir best resultat med tanke på riktig plassering av protesen, som igjen har 
betydning for hvor lenge protesen varer før den evt må skiftes ut. Vi vil også undersøke 
hvilken metode som gir minst sykelighet og komplikasjoner etter operasjonen. Funksjon og 
livskvalitet vil bli vurdert, også i et helseøkonomisk perspektiv. 
 
De blir herved forespurt om De vil delta i en studie som har til hensikt å sammenligne 
behandlingsresultatet med disse to metodene.  
 
Hva innebærer deltakelse i studien? 
Studien innebærer at man ved loddtrekning velger hvilken metode pasienten skal opereres 
med.  Plassering av reflektorkuler for computernavigering innebærer to små (1cm) hudsnitt på 
leggen. Kulene festes med pinner som skrues fast i benet. Begge grupper vil få dette 
hudsnittet. Oppfølgingen vil også være den samme uavhengig av metoden. Pasienter som 
deltar i studien, vil under operasjonen få satt inn små metallmarkører (0,8-1mm) av metallet 
tantal i benet rundt protesen og i plastkomponenten. Disse metallmarkørene har vært benyttet 
til dette formålet internasjonalt i flere tiår og har ingen påviste bivirkninger. Ved hjelp av 
markørene og helt spesielle røntgenbilder kan man påvise mikroskopisk bevegelse av 
protesedelene og slitasje av plasten. Grad av bevegelse og slitasje sier noe om protesens 
stabilitet og derved kvalitet. Pasienter som deltar i studien vil få en ekstra nøye oppfølging 
med røntgenundersøkelser etter 3, 12 og 24 måneder, samt vanlig rtg. kontroll og 
undersøkelse etter 5 og 10 år. Det vil dessuten bli foretatt en CT-kontroll av kneet 3 måneder 
etter operasjonen for å sjekke protesens plassering. Dette medfører en strålebelastning på 1 
mSv som tilsvarer 3 røntgenbilder av bekkenet.  
 
Håndtering av opplysninger og Personvern 
Deltagelse er frivillig, og De kan trekke dem fra studien, også etter operasjon. Dersom De 
velger ikke å delta i studien, vil dette ikke ha noen innvirkning på Deres behandling ved 
sykehuset, og De vil bli operert på vanlig måte med en standard Profix kneprotese. 
De opplysninger og data som framkommer gjennom studien vil samles og databehandles.  
Dataene tas fra din vanlige pasientjournal fra opphold ved innleggelse for operasjon, 
påfølgende rtg. og polikliniske kontroller hos lege og fysioterapeut. Vi registrerer plassering 
av protesen, bevegelse av protese, grad av smerte, funksjon, andre sykdommer, evt. 
bivirkninger og bruk av medikamenter. I tillegg vil fysioterapeuten evaluere 
opptreningsperioden med et eget spørreskjema. Studien er et samarbeidsprosjekt mellom 
Haugesund sjukehus, Haugesund sanitetsforenings revmatismesjukehus, Lovisenberg 
Diakonale Sykehus og Haukeland Universitetssykehus. Opplysninger om enkeltpasienters 
identitet vil bli oppbevart ved hvert behandlende sykehus, mens data samlet inn i prosjektet 
vil bli utvekslet mellom sykehusene i avidentifisert form. Alle opplysningene vil bli behandlet 
konfidensielt. Prosjektet avsluttes år 2017, etter 10 års oppfølging av alle pasienter, og alle 
innsamlede forskningsdata vil da anonymiseres. Vanlige journalopplysninger vil ikke slettes. 
 
Studien er klarert av Regional komité for medisinsk forskningsetikk Vest-Norge og meldt til 
Personvernombudet for forskning, Norsk samfunnsvitenskapelig datatjeneste AS.  
 
Studien ledes av Klinikkoverlege professor dr. med. Ove Furnes, ved Ortopedisk avd. 
Haukeland Universitetssykehus. 
 
Spørsmål vedrørende studien kan rettes til din behandlende lege, eller til legen som er 





























Undertegnede har lest den vedlagte informasjonen og har diskutert studien med 
ansvarlig lege. Jeg er villig til å delta i studien. 
 
______________________________________  _________________________ 
Pasientsignatur     Dato: 
       (Pasienten skriver selv dato) 






Som ansvarlig lege bekrefter jeg at pasienten har fått muntlig og skriftlig informasjon 
om studien, og at pasienten har signert samtykke før prosjektspesifikke undersøkelser 
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PASIENTSKJEMA;  






Kjønn: Mann____Kvinne___(sett kryss) 
 
Diagnose: 
1. Primær gonartrose 
2. Sequele fraktur 
3. RA 
4. Psoriasis / Bechterev 
5. Annet. Presiser:…………. 
 
Side:  Hø 
  Ve 
 
Charnley klasse:  A   -Unilateral knelidelse 
    B   -Bilateral knelidelse 
C   -Multippel leddlidelse eller annen sykdom som nedsetter 
gangfunksjonen 
 
Status i kontralaterale kne: 
1. Normal funksjon 
2. Moderat nedsatt funksjon 
3. Alvorlig nedsatt funksjon 
 
Tidligere inngrep i aktuelle kne: 
1. Åpen/Artroskopisk meniskreseksjon/debridement 
a. 0-1 år siden 
b. >1 år siden 




d. Kombinasjon av ovennevnte 
3. Artroskopisk båndoperasjon 
a. ACL 
b. Annet (inkl pcl, mcl, lcl, menisksutur etc) 
  
Tidligere sykdommer: 
1. DVT i aktuelle underekstremitet 




6. Annen hjerterytmeforstyrrelse 
7. Hjerteklaff-sykdom  
8. TIA 
9. Sequele etter hjerneslag/hjerneblødning 
10. Revmatoid artritt 
11. Psoriasis artritt 
12. Polyartritt 
 










seponert preop – sett 
kryss) 
1. Marevan                   mg pr uke    
2. Albyl-E             mg pr dag    
3. Plavix             mg pr dag    
4. Ticlid             mg pr dag    
5. Persantin             mg pr dag    
6. Annet 
antitrombotikum 








  Preoperativt:  Hb_____ 
     Hct____ 
  Postoperativt dag 2-3: Hb_____ 
     Hct____ 
 
























7. Utstyrssvikt (spesifiser!) 
8. Annet 
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Survivorship and relative risk of revision in computer-navigated 
versus conventional total knee replacement at 8-year follow-up 
A study of 23,684 cases reported to the Norwegian Arthroplasty Register, 
2005–2014
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Background and purpose — The long-term effects of computer-
assisted surgery in total knee replacement (CAS) compared to 
conventionally operated knee replacement (CON) are still not 
clear. We compared survivorship and relative risk of revision in 
CAS and CON based on data from the Norwegian Arthroplasty 
Register.
Patients and methods — We assessed primary total knee 
replacements without patellar resurfacing reported to the Norwe-
gian Arthroplasty Register from 2005 through 2014. The 5 most 
used implants and the 3 most common navigation systems were 
included. The groups (CAS, n = 3,665; CON, n = 20,019) were 
compared using a Cox regression analysis adjusted for age, sex, 
ASA category, prosthesis brand, fi xation method, previous sur-
gery, and diagnosis with the risk of revision for any reason as end-
point. Secondary outcomes were reasons for revision and effects 
of prosthesis brand, fi xation method, age (± 65 years), and hospi-
tal volume.
Results — Prosthesis survival and risk of revision were similar 
for CAS and CON. CAS had signifi cantly fewer revisions due to 
malalignment. Otherwise, no statistically signifi cant difference 
was found between the groups in analyses of secondary outcomes. 
Mean operating time was 13 minutes longer in CAS.
Interpretation — At 8 years of follow-up, CAS and CON had 
similar rates of overall revision, but CAS had fewer revisions due 
to malalignment. According to our fi ndings, the benefi ts of CAS at 
medium-term follow-up are limited. Further research may iden-
tify subgroups that benefi t from CAS, and it should also empha-
size patient-reported outcomes.
■
In total knee replacement (TKR), alignment of the implant 
is considered important to achieve a satisfactory outcome 
(Jeffery et al. 1991, Ritter et al. 2011, Huang et al. 2012). 
Computer-assisted surgery (CAS) is widely used to improve 
implant positioning, and several randomized trials and meta-
analyses have concluded that CAS provides more accurate 
alignment of the implant (Choong et al. 2009, Hetaimish et al. 
2012, Cip et al. 2014, Rebal et al. 2014, Shi et al. 2014). CAS 
has been shown to have a short learning curve and is claimed 
to be useful in training of inexperienced surgeons (Jenny et 
al. 2008, Smith et al. 2010). Still, the long-term effects on 
survival and causes of revision for CAS as opposed to con-
ventionally operated TKR (CON) are not clear (Burnett and 
Barrack 2013). 
A randomized, controlled trial in Norway found improved 
alignment and marginally better functional outcome with CAS 
1 year after surgery (Gothesen et al. 2014). Nevertheless, a 
2-year follow-up from the Norwegian Arthroplasty Regis-
ter (NAR) in 2011 showed a higher revision rate with use of 
computer navigation (Gothesen et al. 2011). Data from the 
New Zealand National Joint Registry with 5 years of follow-
up showed similar revision rates and functional outcomes 
between navigated and non-navigated TKR (Roberts et al. 
2015). On the other hand, a recent study from the Australian 
Orthopaedic Association National Joint Replacement Registry 
found a lower cumulative revision rate for computer naviga-
tion in patients less than 65 years (de Steiger et al. 2015). 
The purpose of this study was to use the large cohort from 
the nationwide Norwegian Arthroplasty Register to investigate 
medium-term effects of computer navigation in primary total 
knee replacement by comparing CAS and CON, with risk of 
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revision for any reason as endpoint. We also wanted to deter-
mine how CAS affected the rate and causes of revision in dif-
ferent prosthesis brands, fi xation methods, and age groups, and 
to analyze the learning curve and the impact of hospital volume.
Patients and methods
Sources of data
This prospective observational study was based on data from 
the Norwegian Arthroplasty Register (NAR). The NAR was 
established in 1987 as a national hip registry (Havelin et al. 
2000). From 1994, registration also included knee prostheses 
and other joint replacements (Furnes et al. 2002). The regis-
try covers a population of approximately 5.2 million and the 
completeness of registration is 95% for primary TKR and 89% 
for revision TKR (Espehaug et al. 2006, Havelin et al. 2015). 
Registration of CAS started in 2005. In 2014, 8% of knee 
prostheses were implanted with CAS (Havelin et al. 2015). 
36,863 primary total knee replacements without patellar 
resurfacing were reported to the NAR from January 1, 2005 
through December 31, 2014. As only 2.5% of the knees were 
patella resurfaced during this period, prostheses with a patel-
lar component were excluded. Hinged (n = 48), bi-compart-
mental (n = 3), and reverse hybrid implants (cemented femur 
and uncemented tibia, n = 10) were also excluded due to low 
numbers. The cohort was divided into 2 groups according to 
the surgical technique used for the implantation: either the 
CAS technique or CON (Figure 1). 
In the short-term follow-up study from the NAR in 2011, the 
5 most used prosthesis brands (AGC, Duracon, e.motion, LCS 
complete, and Profi x) and the 3 most frequently used naviga-
tion systems (Brainlab, Orthopilot, and Stryker) were selected 
for analysis. We used the same selection criteria to compare 
the results with the study from 2011 (Gothesen et al. 2011). 
31, 2014). Information about deaths and emigrations until 
December 31, 2014 was obtained from the National Population 
Register. To ensure that deaths and emigrations did not affect 
the results, this was tested in a competing-risk model (Fine and 
Gray 1999).
The null hypothesis was that there would be no difference 
in survival or relative risk of revision in total knee arthro-
plasty performed with CAS and with CON. The relative risk 
(RR) was calculated using a Cox multiple regression model, 
to make a statistical comparison of the survival rates of the 
groups, adjusted for age (continuous), sex, prosthesis brand, 
ASA category (1/2/3+), fi xation method (cemented/unce-
mented/hybrid (uncemented femur, cemented tibia)), diag-
nosis (osteoarthritis/other), and previous surgery of the knee 
(yes/no). The Cox regression analyses were also performed 
with adjustments for a propensity score with the same covari-
ates as above in addition to side (left/right), peroperative 
complications (yes/no), and defi ciency of anterior cruciate 
ligament preoperatively and posterior cruciate ligaments pre-
operatively and postoperatively (yes/no). The proportional 
hazards assumption of the Cox regression model was assessed 
by visual inspection (log-minus-log plot). 
Main causes of revision were determined based on the hier-
archy from the Australian Orthopaedic Association National 
Joint Replacement Registry (2015), modifi ed according 
to causes of revision registered in the NAR (Table 3). The 
adjusted RR estimates for CAS relative to CON are reported 
with 95% confi dence intervals (CIs) and p-values. Survival 
curves were constructed by Cox regression with CAS as strati-
fi cation factor, with the same adjustments as described above.
In subanalyses, we investigated the effect of CAS on sur-
vival in different brands of prosthesis, in different fi xation 
methods, and in patients younger or older than 65 years of age. 
To investigate possible effects of a learning curve, we split the 
data fi le in order to analyze the fi rst 30 computer-navigated 
 
Computer navigated (CAS) 
n = 4,597 
Missing a (n = 3,423)  
Reverse hybrid (n = 20)
 
Missing b (n = 127)
(113 CON, 14 CAS) 
Conventionally operated (CON)






Other prosthesis brands 


















n = 344 
Excluded: 
Other prosthesis brands
or navigation systems 
n = 932 
ACG, Duracon, Profix,
e.motion, LCS Complete
operated with Stryker, 
BrainLab, Orthopilot 
n = 3,665 
Patella non-resurfaced primary TKR
reported to NAR, 2005–2014
n = 36,863
Statistics
Baseline characteristics of the 
groups were investigated by 
descriptive analysis. Differ-
ences in demographic vari-
ables were calculated using 
chi-square test and Student’s 
t-test, assuming equal vari-
ances. Median follow-up 
was calculated using reverse 
Kaplan-Meier (Schemper and 
Smith 1996). Implant survival 
(time from operation to fi rst 
revision) was estimated by 
Kaplan-Meier analysis after 
5 and 8 years of follow-up, 
with censoring at the time of 
death, emigration, or at the 
end of inclusion (December 
Figure 1. Selection of patients. TKR: total knee replacement; NAR: Norwegian Arthroplasty Register; CAS: 
computer-navigated knee replacement; CON: conventionally operated knee replacement. a No information 
on use of computer navigation. b No information on fi xation method.
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procedures (learning group) at each center and the remaining 
procedures (experienced group) separately, since the learn-
ing curve for computer navigation in TKR has been shown to 
stabilize after 30 procedures (Nizard et al. 2004, Jenny et al. 
2008). Operation time is presented as median and interquartile 
range (IQR) and differences in operation time were calculated 
using Mann-Whitney tests.
All tests were 2-sided, and the signifi cance level was set at 
0.05. Statistical analyses were performed using IBM SPSS 
Statistics version 22. 
Ethics
The NAR has permission from the Norwegian Data Inspector-
ate to collect patient data, based on obtaining written consent 
from the patient. (Permission was last issued September 15, 
2014; reference number 03/00058-20/CGN).
Results
In the CAS group, the patients were 1 year younger on aver-
age, with males predominating, and they had a lower mean 
ASA score than the CON group (Table 1). Use of uncemented 
prostheses, previous surgery of the knee, and preoperative 
defi ciency of the ACL was more frequent in the CAS group. 
Median follow-up was 5.3 years in the CAS group and 5.0 
years in the CON group. 65 different hospitals were repre-
sented. All 22 hospitals that used CAS performed both tech-
niques. For the implants included, the number of CAS opera-
tions during the study period varied between > 200 TKRs in 3 
hospitals and < 30 TKRs in 5 hospitals. In the CON group, 33 
hospitals had a volume of > 200. 
Overall survivorship (Table 2)
At 5-year follow-up, the survival rate in the CON group was 
95.5% (CI: 95.1–95.9) and  it was 95.7% (CI: 94.9–96.5) in 
the CAS group. At 8 years, the survival rate was 94.9% (CI: 
94.5–95.3) in the CON group and 94.8% (CI: 93.8–95.8) in 
the CAS group (Figure 2). The Cox regression analysis did 
not show any statistically signifi cant difference in risk of revi-
sion between the CAS group and the CON group (RR = 0.8, 
CI: 0.7–1.0; p = 0.1); nor did the propensity score-adjusted 
Cox regression analysis (RR = 0.8, CI: 0.7–1.1; p = 0.1). The 
robustness of the analysis was investigated further with a sim-
pler Cox regression model adjusted for age, sex, and diagnosis, 
and this RR estimate was 0.95 (CI: 0.80–1.13; p = 0.6). The 
Cox-adjusted RR was also tested for 0–2 years and 2–8 years 
after surgery, separately, but there was still no statistically 
signifi cant difference in relative risk of revision between the 
groups. The proportion of deaths was 8.0% in the CAS group 
and 10% in the CON group, and the proportion of emigrations 
was 0.4% in both groups. In the competing-risk model, the 
overall relative risk of revision for CAS versus CON was 0.9 
(CI: 0.8–1.2; p = 0.7) and for patients < 65 years, the relative 
risk of revision was 0.9 (CI: 0.8–1.2, p = 0.8).
Secondary outcomes
We also performed Cox regression analyses comparing CAS 
and CON for each selected prosthesis brand. In analyses 
adjusted for age, sex, ASA category, fi xation method, and 
diagnosis, there was no statistically signifi cant difference in 
risk of revision for Profi x, LCS complete, AGC, or Duracon. 
For the e.motion prosthesis (352 CAS, 8 CON), there were 
6 revisions in the CAS group and no revisions in the CON 
group, so an RR could not be estimated.
Table 1. Demographic data for computer-navigated total knee 
replacement (CAS) and conventionally operated total knee replace-
ment (CON) 
   CAS CON p-value
Number 3,665 20,019  
Men, % 38 35 < 0.001
Age, years 68.4 69.2 < 0.001
  95% CI 68.1–68.7 69.1–69.3  
Right knee, % 54 54 0.9
MIS a, n (%) 21 (0.6) 65 (0.4) 0.02
ASA category b, n (%)     0.01
  1 602 (16) 3316 (17)  
  2 2,378 (65) 12,506 (62)  
  3+ 640 (18) 3,944 (20)  
  Missing 45 (1) 253 (1)  
Diagnosis preoperatively, %     0.02
  Primary gonarthritis 82 84  
  Other 18 16  
  Missing 0.1 0.2  
Fixation method, n (%)     < 0.001
  Cemented 2,081 (57) 16,418 (82)  
  Uncemented 1,456 (40) 344 (2)  
  Hybrid (uncemented femur) 114 (3) 3,144 (16)  
  Missing 14 (0.4) 113 (0.6)  
Prosthesis brand, n (%)     < 0.001
  AGC 94 (3) 2,054 (10)  
  Duracon 629 (17) 1,368 (7)  
  e.motion 352 (10) 8 (0)  
  LCS complete 1,387 (38) 8,408 (42)  
  Profi x 1,203 (33) 8,181 (41)  
Previous operations of the knee, % 38 31 < 0.001
  Osteosynthesis affecting 
    the knee joint 2.7 1.9 < 0.001
  Osteotomy 3.5 3.3 0.6
  Synovectomy 1.3 1.9 0.02
  Other 33 25 < 0.001
Peroperative complication, % 1.8 2.1 0.2
Intact ACL c preoperatively, % 76 81 < 0.001
Intact PCL d preoperatively, % 95 94 0.1
Intact PCL postoperatively, % 57 56 0.3
Hospital volume 2005–2014, n e      
  1–30 6 12  
  31–100 7 9  
  101–200 6 11  
  > 200 3 33  
  Total number of hospitals 22 65 
 
a MIS: minimally invasive surgery.      
b ASA category: American Society of Anesthesiologists physical 
status classifi cation system. 
c ACL: anterior cruciate ligament.      
d PCL: posterior cruciate ligament.      
e Number of hospitals. 
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When selecting cemented prostheses only (2,080 CAS, 
16,418 CON), there was still no signifi cant difference in our 
Cox-adjusted estimates for risk of revision (RR = 0.9, CI: 0.7–
1.1; p = 0.4). For hybrid implants (114 CAS, 3,143 CON), the 
Cox-adjusted relative risk was 1.2 (CI: 0.4–3.9; p = 0.7). Only 
Profi x and LCS complete were used as uncemented implants. 
Uncemented Profi x implants (836 CAS, 27 CON) had 6 revi-
sions reported, all in the CAS group. For the uncemented LCS 
compete (619 CAS, 316 CON), no signifi cant difference was 
found (RR = 0.8, CI: 0.5–1.3; p = 0.3). 
We did not fi nd any statistically signifi cant difference in 
overall risk of revision between CAS and CON in patients 
who were older and younger than 65 years (Figure 3). Patients 
< 65 years of age had a lower risk of revision in the CAS 
group, with RR = 0.8, but this was not statistically signifi -
cant (CI: 0.6–1.1; p = 0.1). For patients ≥ 65 years of age, 
the relative risk was 0.9 (CI: 0.7–1.2; p = 0.6). Analyses of 
fi xation method in patients < 65 years of age did not indicate 
that CAS affected the revision risk differently for cemented, 
uncemented, or hybrid implants. The use of computer naviga-
tion did not affect the Kaplan-Meier survival rate after 5 or 8 
years (Table 2).
3 hospitals were using both techniques (CAS and CON), 
and were regarded as high-volume centers with more than 
300 computer-navigated TKRs. 1 hospital mainly used Profi x 
(hospital A: 917 CAS, 137 CON), and the other 2 used LCS 
complete (hospital B: 342 CAS, 183 CON; hospital C: 578 
CAS, 55 CON). We compared the 2 techniques in these hos-
Table 2. Kaplan-Meier survival (KM) and Cox-adjusted relative risk of revision for computer-navigated total knee replacement (CAS) 
and for conventionally operated total knee replacement (CON)
  5 years 8 years Cox regression
  MF a, years   KM survival  KM survival Cox-adjusted RR b adjusted by PS c
  (95 % CI) At risk (95 % CI) At risk (95 % CI) (95% CI)     p-value (95% CI)    p-value
All ages              
 CAS 5.3 (5.2–5.4) 1,965 95.7 (94.9–96.5) 354 94.8 (93.8–95.8) 0.8 (0.7–1.0) 0.1 0.8 (0.7–1.1) 0.1
 CON 5.0 (4.9–5.0) 9,509 95.5 (95.1–95.9) 2,836 94.9 (94.5–95.3) 1  1
< 65 years              
 CAS 6.1 (5.7–6.5) 695 93.6 (92.2–95.0) 126 93.6 (92.2–95.0) 0.8 (0.6–1.1) 0.1 0.8 (0.6–1.1) 0.1
 CON 5.4 (5.2–5.5) 3,102 93.1 (92.5–93.7) 955 92.4 (91.6–93.2) 1  1
a MF: median follow-up (reversed KM).
b RR: relative risk, CAS versus CON, adjusted for age, sex, ASA category, diagnosis, previous surgery of the knee, prosthesis brand, 
and fi xation method.
c PS: propensity score. Covariates included in PS are the same as in the Cox-adjusted RR in addition to side, peroperative complica-
tions, and defi ciency of anterior cruciate ligament preoperatively and posterior cruciate ligaments preoperatively and postoperatively.
Figure 2. Kaplan-Meier survival curves with 95% confi dence intervals 
(broken lines) for computer-navigated total knee replacement (CAS) 
and conventionally operated (CON) total knee replacement. Log-rank 
test: p = 0.9. 8 years at risk: CAS, n = 354; CON, n = 2,836.
Figure 3 Cox regression survival curves with 95% confi dence intervals 
(broken lines) for computer-navigated total knee replacement (CAS) 
and conventionally operated total knee replacement (CON) in patients 
who were more than or less than 65 years of age, adjusted for sex, 
ASA category, diagnosis, previous surgery, prosthesis brand, and fi xa-
tion method. 8 years at risk: ≥ 65 years old: CAS, n = 228; CON, n = 
1,881; < 65 years old: CAS, n = 126; CON, n = 955.
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pitals separately. All 3 high-volume hospitals had small, sta-
tistically insignifi cant differences in the risk of revision when 
CAS and CON were compared. 
Median operating time was 100 min (IQR: 35) in the CAS 
group and 89 min (IQR: 25) in the CON group (p < 0.001). 
When only cemented implants were selected, median operat-
ing time was 111 min (IQR: 31) for CAS and 90 min (IQR: 
32) for CON (p < 0.001).
Learning curve
The learning group involved 533 computer-navigated (CAS) 
knee procedures in 22 different hospitals and the experienced 
group involved 3,140 CAS procedures in 15 different hospitals. 
Comparison of the learning group with the entire CON group 
did not reveal any difference in risk of revision (RR = 1.1, CI: 
0.7–1.5; p = 0.9). Median operating time for the learning CAS 
group was 31 min longer than for CON (p < 0.001). In the expe-
rienced CAS group, the risk of revision relative to CON was 
0.8 (CI: 0.7–1.0; p = 0.09). Median operation time was 17 min 
longer with CAS (p < 0.001) for all fi xation methods and 19 
minutes longer with CAS for cemented implants (p < 0.001).
Causes of revision (Table 3)
Deep infection and aseptic loosening were the most common 
causes of revision, except in CAS patients aged < 65 years, 
where revision due to instability was more frequent. When we 
adjusted for age, sex, ASA class, diagnosis, prosthesis brand, 
and fi xation method, the CAS group had fewer revisions due 
to malalignment, with RR = 0.5 (CI: 0.3–0.9; p = 0.02) in all 
patients and RR = 0.3 (CI: 0.1–0.8; p = 0.01) in patients who 
were < 65 years old. Otherwise, there were no statistically sig-
nifi cant differences in risk of revision for the causes reported.
Discussion 
We used data from the Norwegian Arthroplasty Register to 
compare survival, relative risk of revision, and causes of revi-
sion in total knee replacements performed with conventional 
methods or computer navigation. After 8 years of follow-up, 
we did not fi nd any statistically signifi cant differences in sur-
vival between groups. In subanalyses, we could not detect any 
difference in RR of revision for CAS and CON, either for dif-
ferent prosthesis brands or hospital volumes. Computer navi-
gation did not affect the outcome differently with certain fi xa-
tion methods or in patients less than 65 years. Risk of revision 
was not elevated in the fi rst 30 computer-navigated cases at 
each center compared to the risk for the later procedures. CAS 
had statistically signifi cantly fewer revisions due to malalign-
ment. 
Strengths and limitations
This registry-based study involved a large number of patients 
from all surgical units that perform total knee replacements 
in Norway (Espehaug et al. 2006, Havelin et al. 2015). Selec-
tion of the 5 most frequently used prosthesis brands and the 
3 most frequently used navigation systems strengthened the 
applicability and external validity. The high completeness of 
reporting led to good external validity and 8 years of follow-
up enabled us to discover possible complications of computer 
navigation, such as higher rates of infection and  fracture, or 
advantages. 
Despite the high quality of the NAR database and the reg-
istry study design, there were some limitations. Because of 
the low revision rate of knee prostheses, a large cohort and 
a long follow-up time were required to uncover benefi ts or 
Table 3. Reasons for revision in computer-navigated total knee replacement (CAS) and conventionally operated total knee replacement 
(CON) for all patients and for patients less than 65 years of age
   All ages  < 65 years old   
    CAS CON CAS vs. CON c  CAS CON CAS vs. CON c
No a  n % b n % b RR (95% CI)    p-value   n % b n % b RR (95% CI)    p-value 
1 Deep infection 40 26 202 24 1.0 (0.6–1.4) 0.8  17 20 81 20 0.7 (0.4–1.3) 0.3
2 Malalignment 15 10 90 11 0.5 (0.3–0.9) 0.02  5 6 49 12 0.3 (0.1–0.8) 0.01
3 Aseptic loosening 33 21 190 23 1.1 (0.7–1.6) 0.7  17 20 99 24 1.0 (0.6–1.8) 0.9
4 Instability 29 19 112 14 0.7 (0.4–1.2) 0.2  22 27 63 15 0.9 (0.5–1.7) 0.7
5 Periprosthetic fracture 4 3 14 1.7 0.5 (0.1–2.1) 0.4  1 1 4 1.0 0.6 (0.04–7.9) 0.7
6 Decreased range of motion d 5 3 34 4.1 0.8 (0.3–2.3) 0.7  5 6 22 5.4 1.4 (0.4–4.5) 0.6
7 Other e 6 4 56 6.8 0.6 (0.2–1.6) 0.3  1 1 26 6.3 0.1 (0.01–1.0)  0.05
8 Pain only 24 15 125 15 1.1 (0.6–1.9) 0.7  15 18 66 16 1.2 (0.6–2.5) 0.6
  Missing 0 0 4 0.5     0 0 1 0.2                         
  No. of revisions 156   827       83   411    
  No. of total knee replacements 3,665   20,019       1,292   6,481    
a Listed in the same order as hierarchy for determination of main cause of revision.
b Percentage of  number of revisions.
c Adjusted for age, sex, prosthesis brand, ASA category, fi xation method (cemented, uncemented, hybrid), diagnosis (OA, other), and previous 
   surgery of the knee (yes, no).
d Including arthrofi brosis and joint stiffness.
e Including dislocation (patella and other), polyethylene wear, and progression of arthrosis.
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small disadvantages in the study group. Serving a population 
of approximately 5.2 million citizens, the Norwegian regis-
try has smaller numbers of operations than registries in larger 
countries, and is thus underpowered to detect small differ-
ences. This limitation was especially noticeable in some sub-
analyses with low numbers of revisions, and these results are 
less conclusive. Additionally, the different prosthesis brands 
and the use of computer navigation were unequally distrib-
uted among the hospitals. Consequently, the effect of single 
surgeons or differences in patient demographics between the 
hospitals may have affected the results, especially in the sub-
analyses where the number of patients was low. Complica-
tions that do not lead to revision of the prosthesis are not regis-
tered in the database. Thus, fractures or infections in pinholes 
after CAS are usually not registered. Common confounding 
factors were treated by adjustments in the statistical analy-
ses, but we cannot account for unmeasured differences such 
as surgeon volume and postoperative treatment. In contrast to 
randomized trials, uncontrolled confounders might also have 
had a role. Adjustment for many different confounding fac-
tors increases the risk of overadjustment bias (Schisterman et 
al. 2009) and a Cox model only adjusted for age, sex, and 
diagnosis was performed to address this problem. However, 
inclusion of death in a competing risks model, and also the 
Cox model with fewer adjustments, did not alter the conclu-
sions in our study.
Comparison with other studies
In a short-term follow-up from the NAR (Gothesen et al. 
2011), the risk of revision was higher with CAS than with 
CON, and the LCS complete had inferior results than other 
prosthesis brands in the CAS group. At 8-year follow-up, 
we could no longer detect these differences. The short-term 
results might be caused by challenges during the introduction 
period of this new technology. Even so, we could not detect 
a learning curve, which supports previous fi ndings that sur-
geons achieve satisfactory results with computer navigation 
shortly after introduction (Jenny et al. 2008, Chinnappa et 
al. 2015). There have been few studies comparing different 
implant designs in computer-aided navigation, but the LCS 
complete has also shown inferior results in registry-based 
studies both in Norway and in the USA (the Kaiser Perma-
nente Total Joint Arthroplasty Registry) with conventional 
surgery (Paxton et al. 2011, Gothesen et al. 2013) and with 
mobile-bearing knee replacement in general (Namba et al. 
2014). Baker et al. (2012) found that implant brand and hos-
pital type affected patient-reported outcome. Thus, it is likely 
that the inferior results with the LCS complete in the short 
term were mainly caused by the prosthesis design and chal-
lenges during introduction of new technology, rather than by 
the use of CAS.
In 2015, arthroplasty registries in New Zealand and Austra-
lia published studies on computer navigation in TKA, with 5 
and 9 years of follow-up (respectively). The Australian reg-
istry reported a reduced revision rate for computer-navigated 
procedures in patients less than 65 years of age, and there was 
a reduction in revision rate due to loosening (de Steiger et al. 
2015), but only with adjustment for age and sex. In a group of 
equivalent age, the arthroplasty registry in New Zealand found 
a trend of a higher revision rate for Triathlon implants inserted 
with computer-assisted navigation (not statistically signifi -
cant) (Roberts et al. 2015). We found a statistically insigni-
fi cantly lower revision rate and also lower risk of loosening 
in patients who were less than 65 years in the CAS group, 
supporting the Australian results. The smaller number of cases 
in our registry may explain why we were unable to detect a 
signifi cant difference. 
Improved alignment with CAS is expected to give better 
resistance to aseptic loosening and lower wear of the implant, 
as well as better functional results. We found a lower risk of 
revision due to malalignment, but this did not affect the overall 
survival or the risk of revision. There is evidence that malalign-
ment is associated with implant failure (Jeffery et al. 1991, 
Huang et al. 2012) and a recent review article by Gromov et 
al. (2014) recommended aiming for optimal alignment of the 
components in TKA. On the other hand, Parratte et al. (2010) 
found no difference in survivorship for knees with mechanical 
axis within 3° of neutral compared to malaligned knees in a 
retrospective study with 15 years of follow-up. Bellemans et 
al. (2012) emphasized the importance of recognizing patients 
with constitutional varus, and Vanlommel et al. (2013) showed 
that these patients had superior clinical outcomes when the 
alignment was left in mild varus. In these cases, computer 
navigation could in theory cause a poorer outcome by cor-
recting the patient’s natural alignment. As an alternative to 
mechanically aligned TKA, some surgeons prefer to have the 
prostheses kinematically aligned. A study by Howell et al. 
(2013) showed similar Oxford knee scores in kinematically 
aligned knees regardless of alignment, and a randomized, con-
trolled trial by Dossett et al. (2014) found superior functional 
outcome and pain relief in kinematically aligned TKAs than 
in mechanically aligned TKAs. These different approaches 
might also play an important role in the success of TKA.  
Analysis of registry data is limited to the information col-
lected in the registry. The Norwegian Arthroplasty Regis-
ter contains no information on radiological measurements 
or functional outcomes. In order to claim causality between 
alignment and survival, radiological measurements of the 
revised cases are required. Our results illustrate that computer-
assisted navigation alone does not change large trends in sur-
vival of knee prostheses. The patient’s health status has been 
suggested to be more important than surgical factors (Baker 
et al. 2012), and alignment may be of less importance than 
previously assumed. 
Future research
Registry studies with a longer follow-up time will provide 
useful information in future assessment of computer naviga-
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tion in TKR. However, to investigate correlations between 
malalignment and functional results, long-term follow-up of 
randomized trials should also be conducted. Radiostereomet-
ric analysis can be helpful in detecting early loosening as a 
predictor of implant failure (Ryd et al. 1995). Collection of 
revised implants for laboratory studies and radiographs for 
alignment measurements from revisions might be useful in 
addition to collection of patient-reported outcome measures 
in arthroplasty registries. These modalities would enable 
researchers to assess revision rates in the context of patient 
satisfaction and function, with a view to improving the quality 
of life of the patients.
Summary
This study has shown similar 8-year survivorship in computer-
navigated TKR and conventionally operated TKR, but CAS 
had fewer revisions for malalignment. We were unable to fi nd 
specifi c benefi ts of CAS in particular age groups or regarding 
particular prosthesis brands. 
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